studyid,siteid,usubjid,trta,trtan,age,agegr1,agegr1n,race,racen,sex,saffl,trtsdt,trtedt,astdt,astdtf,astdy,aendt,aendy,adurn,aduru,aeterm,aellt,aelltcd,aedecod,aeptcd,aehlt,aehltcd,aehlgt,aehlgtcd,aebodsys,aesoc,aesoccd,aesev,aeser,aescan,aescong,aesdisab,aesdth,aeshosp,aeslife,aesod,aerel,aeacn,aeout,aeseq,trtemfl,aoccfl,aoccsfl,aoccpfl,aocc02fl,aocc03fl,aocc04fl,cq01nam,aocc01fl
CDISCPILOT01,701,01-701-1015,Placebo,0,63,<65,1,WHITE,1,F,Y,1/2/2014,7/2/2014,1/3/2014,,2,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1015,Placebo,0,63,<65,1,WHITE,1,F,Y,1/2/2014,7/2/2014,1/3/2014,,2,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1015,Placebo,0,63,<65,1,WHITE,1,F,Y,1/2/2014,7/2/2014,1/9/2014,,8,1/11/2014,10,3,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1023,Placebo,0,64,<65,1,WHITE,1,M,Y,8/5/2012,9/1/2012,8/7/2012,,3,8/30/2012,26,24,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1023,Placebo,0,64,<65,1,WHITE,1,M,Y,8/5/2012,9/1/2012,8/7/2012,,3,NA,NA,NA,,ERYTHEMA,LOCALIZED ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1023,Placebo,0,64,<65,1,WHITE,1,M,Y,8/5/2012,9/1/2012,8/26/2012,,22,NA,NA,NA,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1023,Placebo,0,64,<65,1,WHITE,1,M,Y,8/5/2012,9/1/2012,8/7/2012,,3,8/30/2012,26,24,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1028,Xanomeline High Dose,81,71,65-80,2,WHITE,1,M,Y,7/19/2013,1/14/2014,7/21/2013,,3,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1028,Xanomeline High Dose,81,71,65-80,2,WHITE,1,M,Y,7/19/2013,1/14/2014,8/8/2013,,21,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1034,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,7/1/2014,12/30/2014,8/27/2014,,58,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1034,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,7/1/2014,12/30/2014,11/2/2014,,125,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1047,Placebo,0,85,>80,3,WHITE,1,F,Y,2/12/2013,3/9/2013,2/12/2013,,1,2/12/2013,1,1,DAY,HIATUS HERNIA,HERNIA HIATAL,NA,HIATUS HERNIA,NA,HLT_0159,NA,HLGT_0109,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1047,Placebo,0,85,>80,3,WHITE,1,F,Y,2/12/2013,3/9/2013,2/12/2013,,1,2/12/2013,1,1,DAY,HIATUS HERNIA,HERNIA HIATAL,NA,HIATUS HERNIA,NA,HLT_0159,NA,HLGT_0109,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,701,01-701-1047,Placebo,0,85,>80,3,WHITE,1,F,Y,2/12/2013,3/9/2013,3/6/2013,,23,NA,NA,NA,,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1047,Placebo,0,85,>80,3,WHITE,1,F,Y,2/12/2013,3/9/2013,3/10/2013,,27,NA,NA,NA,,BUNDLE BRANCH BLOCK LEFT,LEFT BUNDLE BRANCH BLOCK,NA,BUNDLE BRANCH BLOCK LEFT,NA,HLT_0281,NA,HLGT_0721,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,1/1/2014,7/9/2014,1/3/2014,,3,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,1/1/2014,7/9/2014,2/20/2014,,51,2/20/2014,51,1,DAY,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,1/1/2014,7/9/2014,2/20/2014,,51,2/22/2014,53,3,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,1/1/2014,7/9/2014,2/21/2014,,52,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,1/1/2014,7/9/2014,3/21/2014,,80,3/21/2014,80,1,DAY,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,1/1/2014,7/9/2014,3/31/2014,,90,3/31/2014,90,1,DAY,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,1/1/2014,7/9/2014,4/19/2014,,109,4/20/2014,110,2,DAY,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,1/1/2014,7/9/2014,4/19/2014,,109,4/22/2014,112,4,DAY,PHARYNGOLARYNGEAL PAIN,SORE THROAT,NA,PHARYNGOLARYNGEAL PAIN,NA,HLT_0130,NA,HLGT_0402,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,1/1/2014,7/9/2014,4/19/2014,,109,4/22/2014,112,4,DAY,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,9,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,1/1/2014,7/9/2014,2/21/2014,,52,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/7/2012,9/16/2012,9/2/2012,,-5,9/7/2012,1,6,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/7/2012,9/16/2012,9/2/2012,,-5,9/7/2012,1,6,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/7/2012,9/16/2012,7/8/2012,,-61,NA,NA,NA,,LOCALISED INFECTION,LOCALIZED INFECTION,NA,LOCALISED INFECTION,NA,HLT_0435,NA,HLGT_0557,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,N,,,,,,,,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/7/2012,9/16/2012,9/2/2012,,-5,9/7/2012,1,6,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/7/2012,9/16/2012,9/2/2012,,-5,9/7/2012,1,6,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/7/2012,9/16/2012,9/7/2012,,1,NA,NA,NA,,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/7/2012,9/16/2012,9/13/2012,,7,NA,NA,NA,,CELLULITIS,CELLULITIS OF LEG,NA,CELLULITIS,NA,HLT_0613,NA,HLGT_0066,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,11/30/2012,1/23/2013,12/2/2012,,3,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,11/30/2012,1/23/2013,12/2/2012,,3,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,11/30/2012,1/23/2013,12/26/2012,,27,12/26/2012,27,1,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,11/30/2012,1/23/2013,12/26/2012,,27,12/26/2012,27,1,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,11/30/2012,1/23/2013,12/2/2012,,3,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,11/30/2012,1/23/2013,12/2/2012,,3,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,11/30/2012,1/23/2013,1/14/2013,,46,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,11/30/2012,1/23/2013,1/19/2013,,51,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,11/30/2012,1/23/2013,1/19/2013,,51,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1118,Placebo,0,52,<65,1,WHITE,1,M,Y,3/12/2014,9/9/2014,NA,,NA,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2/15/2014,8/16/2014,3/9/2014,,23,3/16/2014,30,8,DAY,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2/15/2014,8/16/2014,3/9/2014,,23,3/9/2014,23,1,DAY,PYREXIA,FEVER,NA,PYREXIA,NA,HLT_0310,NA,HLGT_0652,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2/15/2014,8/16/2014,3/9/2014,,23,3/16/2014,30,8,DAY,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2/15/2014,8/16/2014,5/9/2014,,84,5/9/2014,84,1,DAY,EYE SWELLING,EYES SWOLLEN,NA,EYE SWELLING,NA,HLT_0008,NA,HLGT_0466,NA,EYE DISORDERS,EYE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2/15/2014,8/16/2014,5/9/2014,,84,5/9/2014,84,1,DAY,EYE ALLERGY,EYE ALLERGY,NA,EYE ALLERGY,NA,HLT_0256,NA,HLGT_0071,NA,EYE DISORDERS,EYE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2/15/2014,8/16/2014,5/22/2014,,97,NA,NA,NA,,PRURITUS,ITCHING BOTH HANDS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2/15/2014,8/16/2014,5/22/2014,,97,NA,NA,NA,,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1133,Xanomeline High Dose,81,81,>80,3,WHITE,1,F,Y,10/28/2012,4/28/2013,12/27/2012,,61,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1133,Xanomeline High Dose,81,81,>80,3,WHITE,1,F,Y,10/28/2012,4/28/2013,12/27/2012,,61,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1133,Xanomeline High Dose,81,81,>80,3,WHITE,1,F,Y,10/28/2012,4/28/2013,12/27/2012,,61,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1133,Xanomeline High Dose,81,81,>80,3,WHITE,1,F,Y,10/28/2012,4/28/2013,12/27/2012,,61,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,5/20/2013,6/26/2013,5/16/2013,,-4,6/2/2013,14,18,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,5/20/2013,6/26/2013,5/16/2013,,-4,6/2/2013,14,18,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,5/20/2013,6/26/2013,6/1/2013,,13,6/2/2013,14,2,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,5/20/2013,6/26/2013,6/3/2013,,15,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,5/20/2013,6/26/2013,6/10/2013,,22,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,5/20/2013,6/26/2013,6/10/2013,,22,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,5/20/2013,6/26/2013,6/10/2013,,22,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,5/20/2013,6/26/2013,6/10/2013,,22,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,5/20/2013,6/26/2013,6/22/2013,,34,NA,NA,NA,,APPLICATION SITE PAIN,APPLICATION SITE PAIN,NA,APPLICATION SITE PAIN,NA,HLT_0342,NA,HLGT_0085,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,5/20/2013,6/26/2013,6/26/2013,,38,NA,NA,NA,,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,5/20/2013,6/26/2013,6/26/2013,,38,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,8/23/2013,2/20/2014,8/25/2013,,3,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,8/23/2013,2/20/2014,8/25/2013,,3,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,8/23/2013,2/20/2014,10/12/2013,,51,11/10/2013,80,30,DAY,LOWER RESPIRATORY TRACT INFECTION,CHEST COLD,NA,LOWER RESPIRATORY TRACT INFECTION,NA,HLT_0052,NA,HLGT_0217,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,8/23/2013,2/20/2014,10/12/2013,,51,11/10/2013,80,30,DAY,LOWER RESPIRATORY TRACT INFECTION,CHEST COLD,NA,LOWER RESPIRATORY TRACT INFECTION,NA,HLT_0052,NA,HLGT_0217,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,8/23/2013,2/20/2014,12/15/2013,,115,12/17/2013,117,3,DAY,FLANK PAIN,FLANK PAIN,NA,FLANK PAIN,NA,HLT_0484,NA,HLGT_0543,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,8/23/2013,2/20/2014,12/17/2013,,117,12/17/2013,117,1,DAY,CALCULUS URETHRAL,URETHRAL CALCULUS,NA,CALCULUS URETHRAL,NA,HLT_0550,NA,HLGT_0414,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,8/23/2013,2/20/2014,1/3/2014,,134,1/3/2014,134,1,DAY,EPISTAXIS,NOSE BLEED,NA,EPISTAXIS,NA,HLT_0386,NA,HLGT_0577,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,8/23/2013,2/20/2014,2/1/2012,D,-569,NA,NA,NA,,DYSPEPSIA,INDIGESTION,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,8,N,,,,,,,,
CDISCPILOT01,701,01-701-1153,Placebo,0,79,65-80,2,WHITE,1,F,Y,9/23/2013,3/16/2014,10/13/2013,,21,11/6/2013,45,25,DAY,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1153,Placebo,0,79,65-80,2,WHITE,1,F,Y,9/23/2013,3/16/2014,10/13/2013,,21,11/6/2013,45,25,DAY,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2/12/2013,3/18/2013,2/12/2013,,1,2/12/2013,1,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2/12/2013,3/18/2013,2/12/2013,,1,2/12/2013,1,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2/12/2013,3/18/2013,2/15/2013,,4,3/19/2013,36,33,DAY,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2/12/2013,3/18/2013,NA,,NA,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,N,,,,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2/12/2013,3/18/2013,3/6/2013,,23,3/7/2013,24,2,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2/12/2013,3/18/2013,2/15/2013,,4,3/19/2013,36,33,DAY,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2/12/2013,3/18/2013,3/19/2013,,36,NA,NA,NA,,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2/12/2013,3/18/2013,3/19/2013,,36,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2/12/2013,3/18/2013,3/19/2013,,36,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1181,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,12/5/2013,12/9/2013,12/9/2013,,5,12/9/2013,5,1,DAY,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2/15/2013,3/24/2013,2/16/2013,,2,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2/15/2013,3/24/2013,2/16/2013,,2,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2/15/2013,3/24/2013,2/16/2013,,2,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2/15/2013,3/24/2013,2/16/2013,,2,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2/15/2013,3/24/2013,3/4/2013,,18,NA,NA,NA,,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2/15/2013,3/24/2013,3/4/2013,,18,NA,NA,NA,,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2/15/2013,3/24/2013,3/21/2013,,35,NA,NA,NA,,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,NA,APPLICATION SITE URTICARIA,NA,HLT_0196,NA,HLGT_0233,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2/15/2013,3/24/2013,3/21/2013,,35,NA,NA,NA,,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,8/3/2012,,13,8/3/2012,13,1,DAY,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,NA,NASAL MUCOSA BIOPSY,NA,HLT_0680,NA,HLGT_0396,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,8/7/2012,,17,9/14/2012,55,39,DAY,SECRETION DISCHARGE,SECRETION DISCHARGE,NA,SECRETION DISCHARGE,NA,HLT_0683,NA,HLGT_0575,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,8/7/2012,,17,9/14/2012,55,39,DAY,ERYTHEMA,ERYTHEMA FACIAL,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,6/1/2010,D,-782,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,N,,,,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,8/7/2012,,17,9/14/2012,55,39,DAY,SECRETION DISCHARGE,SECRETION DISCHARGE,NA,SECRETION DISCHARGE,NA,HLT_0683,NA,HLGT_0575,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,8/7/2012,,17,9/14/2012,55,39,DAY,ERYTHEMA,ERYTHEMA FACIAL,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,9/7/2012,,48,10/6/2012,77,30,DAY,PNEUMONIA,PNEUMONIA,NA,PNEUMONIA,NA,HLT_0251,NA,HLGT_0671,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,Y,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,9/7/2012,,48,9/30/2012,71,24,DAY,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,NA,MUSCULAR WEAKNESS,NA,HLT_0444,NA,HLGT_0211,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,6/1/2010,D,-782,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,9,N,,,,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,9/7/2012,,48,10/6/2012,77,30,DAY,PNEUMONIA,PNEUMONIA,NA,PNEUMONIA,NA,HLT_0251,NA,HLGT_0671,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,10,Y,,,,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,9/7/2012,,48,9/30/2012,71,24,DAY,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,NA,MUSCULAR WEAKNESS,NA,HLT_0444,NA,HLGT_0211,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,11,Y,,,,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,12/5/2012,,137,12/16/2012,148,12,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,12,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,12/5/2012,,137,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,13,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,12/5/2012,,137,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,14,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,7/22/2012,1/20/2013,12/5/2012,,137,12/16/2012,148,12,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,15,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1203,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,2/2/2013,8/3/2013,3/21/2013,,48,3/21/2013,48,1,DAY,EYE LASER SURGERY,EYE LASER SURGERY,NA,EYE LASER SURGERY,NA,HLT_0355,NA,HLGT_0189,NA,SURGICAL AND MEDICAL PROCEDURES,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,11/15/2012,1/12/2013,11/16/2012,,2,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,11/15/2012,1/12/2013,11/21/2012,,7,11/21/2012,7,1,DAY,JOINT DISLOCATION,SHOULDER DISLOCATION,NA,JOINT DISLOCATION,NA,HLT_0035,NA,HLGT_0227,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,11/15/2012,1/12/2013,11/29/2012,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,11/15/2012,1/12/2013,12/9/2012,,25,NA,NA,NA,,SKIN LACERATION,LACERATION OF FACE,NA,SKIN LACERATION,NA,HLT_0075,NA,HLGT_0118,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,11/15/2012,1/12/2013,1/11/2013,,58,NA,NA,NA,,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,11/15/2012,1/12/2013,1/11/2013,,58,NA,NA,NA,,DYSPNOEA,SHORTNESS OF BREATH,NA,DYSPNOEA,NA,HLT_0296,NA,HLGT_0255,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,11/15/2012,1/12/2013,1/14/2013,,61,1/14/2013,61,1,DAY,SUDDEN DEATH,SUDDEN DEATH,NA,SUDDEN DEATH,NA,HLT_0142,NA,HLGT_0272,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,Y,N,Y,N,NONE,,FATAL,9,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,1/11/2014,7/10/2014,1/12/2014,,2,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,1/11/2014,7/10/2014,1/13/2014,,3,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,1/11/2014,7/10/2014,1/20/2014,,10,2/8/2014,29,20,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,1/11/2014,7/10/2014,1/20/2014,,10,2/8/2014,29,20,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,1/11/2014,7/10/2014,1/12/2014,,2,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,1/11/2014,7/10/2014,2/20/2014,,41,3/12/2014,61,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,1/11/2014,7/10/2014,2/20/2014,,41,3/12/2014,61,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,1/11/2014,7/10/2014,3/1/2014,D,50,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,2/13/2014,,7,6/3/2014,117,111,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,2/23/2014,,17,2/23/2014,17,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,2/24/2014,,18,6/12/2014,126,109,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,2/24/2014,,18,6/3/2014,117,100,DAY,SALIVARY HYPERSECRETION,HYPERSALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,2/24/2014,,18,6/3/2014,117,100,DAY,PAROSMIA,STRANGE SMELL SENSATION,NA,PAROSMIA,NA,HLT_0258,NA,HLGT_0471,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,2/24/2014,,18,6/12/2014,126,109,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,3/12/2014,,34,3/27/2014,49,16,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,3/12/2014,,34,3/27/2014,49,16,DAY,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,3/12/2014,,34,3/27/2014,49,16,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,3/12/2014,,34,3/27/2014,49,16,DAY,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,10,Y,,,,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,2/13/2014,,7,6/3/2014,117,111,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,11,Y,,,,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,2/24/2014,,18,6/12/2014,126,109,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,12,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,2/24/2014,,18,6/3/2014,117,100,DAY,SALIVARY HYPERSECRETION,HYPERSALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,13,Y,,,,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,2/24/2014,,18,6/3/2014,117,100,DAY,PAROSMIA,STRANGE SMELL SENSATION,NA,PAROSMIA,NA,HLT_0258,NA,HLGT_0471,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,14,Y,,,,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2/7/2014,5/31/2014,2/24/2014,,18,6/12/2014,126,109,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,15,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1287,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,1/25/2014,7/26/2014,1/26/2014,,2,NA,NA,NA,,SALIVARY HYPERSECRETION,INCREASED SALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1287,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,1/25/2014,7/26/2014,2/22/2014,,29,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1287,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,1/25/2014,7/26/2014,3/9/2014,,44,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1287,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,1/25/2014,7/26/2014,7/9/2014,,166,7/12/2014,169,4,DAY,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1287,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,1/25/2014,7/26/2014,7/9/2014,,166,7/12/2014,169,4,DAY,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,701,01-701-1294,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,M,Y,3/24/2013,6/14/2013,3/22/2013,,-2,3/23/2013,-1,2,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1294,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,M,Y,3/24/2013,6/14/2013,5/19/2013,,57,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1294,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,M,Y,3/24/2013,6/14/2013,5/19/2013,,57,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1294,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,M,Y,3/24/2013,6/14/2013,5/19/2013,,57,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1294,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,M,Y,3/24/2013,6/14/2013,5/19/2013,,57,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,8/30/2013,,2,NA,NA,NA,,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,NA,APPLICATION SITE PERSPIRATION,NA,HLT_0283,NA,HLGT_0403,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,8/30/2013,,2,NA,NA,NA,,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,8/31/2013,,3,NA,NA,NA,,PAIN,STINGING,NA,PAIN,NA,HLT_0314,NA,HLGT_0478,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,9/1/2013,,4,NA,NA,NA,,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,9/2/2013,,5,NA,NA,NA,,PHARYNGOLARYNGEAL PAIN,SORE THROAT,NA,PHARYNGOLARYNGEAL PAIN,NA,HLT_0130,NA,HLGT_0402,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,9/2/2013,,5,NA,NA,NA,,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,9/2/2013,,5,9/3/2013,6,2,DAY,DIZZINESS,DIZZY,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,9/4/2013,,7,NA,NA,NA,,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,9/5/2013,,8,10/8/2013,41,34,DAY,CONTUSION,BRUISE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,12,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,9/15/2013,,18,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,13,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,9/30/2013,,33,NA,NA,NA,,EPISTAXIS,NOSE BLEED,NA,EPISTAXIS,NA,HLT_0386,NA,HLGT_0577,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,14,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,9/5/2013,,8,10/8/2013,41,34,DAY,CONTUSION,BRUISE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,15,Y,,,,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,10/15/2013,,48,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,16,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,10/15/2013,,48,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,17,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,8/29/2013,11/5/2013,9/2/2013,,5,NA,NA,NA,,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,18,Y,,,,,,,,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,5/22/2014,11/20/2014,6/23/2014,,33,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,5/22/2014,11/20/2014,6/23/2014,,33,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,5/22/2014,11/20/2014,6/23/2014,,33,NA,NA,NA,,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,NA,APPLICATION SITE URTICARIA,NA,HLT_0196,NA,HLGT_0233,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,5/22/2014,11/20/2014,9/12/2014,,114,NA,NA,NA,,FATIGUE,TIREDNESS,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,5/22/2014,11/20/2014,11/3/2014,,166,NA,NA,NA,,DYSPHONIA,HOARSENESS,NA,DYSPHONIA,NA,HLT_0073,NA,HLGT_0274,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1324,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,10/2/2012,4/2/2013,10/22/2012,,21,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1324,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,10/2/2012,4/2/2013,12/2/2012,,62,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1324,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,10/2/2012,4/2/2013,12/25/2012,,85,1/16/2013,107,23,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1324,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,10/2/2012,4/2/2013,12/25/2012,,85,1/16/2013,107,23,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1341,Xanomeline Low Dose,54,51,<65,1,WHITE,1,M,Y,1/5/2013,1/26/2013,1/19/2013,,15,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1341,Xanomeline Low Dose,54,51,<65,1,WHITE,1,M,Y,1/5/2013,1/26/2013,1/19/2013,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1341,Xanomeline Low Dose,54,51,<65,1,WHITE,1,M,Y,1/5/2013,1/26/2013,1/26/2013,,22,1/30/2013,26,5,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1341,Xanomeline Low Dose,54,51,<65,1,WHITE,1,M,Y,1/5/2013,1/26/2013,1/26/2013,,22,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1341,Xanomeline Low Dose,54,51,<65,1,WHITE,1,M,Y,1/5/2013,1/26/2013,1/26/2013,,22,1/30/2013,26,5,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1360,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,7/31/2013,8/5/2013,8/2/2013,,3,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1360,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,7/31/2013,8/5/2013,8/2/2013,,3,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1360,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,7/31/2013,8/5/2013,8/5/2013,,6,NA,NA,NA,,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,5/30/2013,11/27/2013,6/14/2013,,16,6/15/2013,17,2,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,5/30/2013,11/27/2013,NA,,NA,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,N,,,,,,,,
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,5/30/2013,11/27/2013,7/16/2013,,48,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,5/30/2013,11/27/2013,NA,,NA,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,N,,,,,,,,
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,5/30/2013,11/27/2013,10/13/2013,,137,10/15/2013,139,3,DAY,BACK PAIN,BACKACHE,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,5/30/2013,11/27/2013,10/13/2013,,137,10/15/2013,139,3,DAY,BACK PAIN,BACKACHE,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,2/7/2013,,4,2/7/2013,4,1,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,2/7/2013,,4,2/7/2013,4,1,DAY,APPLICATION SITE PAIN,APPLICATION SITE PAIN,NA,APPLICATION SITE PAIN,NA,HLT_0342,NA,HLGT_0085,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,3/23/2013,,48,3/26/2013,51,4,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,3/23/2013,,48,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,4/12/2013,,68,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,4/12/2013,,68,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,3/23/2013,,48,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,4/12/2013,,68,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,5/7/2013,,93,5/24/2013,110,18,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,9,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,6/24/2013,,141,6/24/2013,141,1,DAY,CHEST DISCOMFORT,CHEST PRESSURE,NA,CHEST DISCOMFORT,NA,HLT_0593,NA,HLGT_0441,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,10,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,6/24/2013,,141,6/24/2013,141,1,DAY,HEADACHE,FULLNESS HEAD,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,11,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2/4/2013,8/6/2013,7/17/2013,,164,7/26/2013,173,10,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,12,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1387,Placebo,0,87,>80,3,WHITE,1,F,Y,3/12/2014,3/25/2014,3/18/2014,,7,3/18/2014,7,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1387,Placebo,0,87,>80,3,WHITE,1,F,Y,3/12/2014,3/25/2014,3/18/2014,,7,3/18/2014,7,1,DAY,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1392,Placebo,0,78,65-80,2,WHITE,1,M,Y,10/28/2012,4/28/2013,3/16/2013,,140,3/21/2013,145,6,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1392,Placebo,0,78,65-80,2,WHITE,1,M,Y,10/28/2012,4/28/2013,3/16/2013,,140,3/21/2013,145,6,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,9/23/2013,3/24/2014,10/21/2013,,29,11/4/2013,43,15,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,9/23/2013,3/24/2014,10/21/2013,,29,11/4/2013,43,15,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,9/23/2013,3/24/2014,12/2/2013,,71,NA,NA,NA,,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,9/23/2013,3/24/2014,1/21/2014,,121,2/10/2014,141,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,9/23/2013,3/24/2014,1/21/2014,,121,2/10/2014,141,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,9/23/2013,3/24/2014,3/9/2014,,168,3/9/2014,168,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1442,Xanomeline Low Dose,54,57,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,10/26/2013,4/26/2014,1/10/2014,,77,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,1/5/2013,2/12/2013,1/19/2013,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,1/5/2013,2/12/2013,1/19/2013,,15,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,1/5/2013,2/12/2013,1/19/2013,,15,NA,NA,NA,,SALIVARY HYPERSECRETION,HYPERSALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,1/5/2013,2/12/2013,1/19/2013,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,1/5/2013,2/12/2013,1/19/2013,,15,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,1/5/2013,2/12/2013,2/4/2013,,31,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,1/5/2013,2/12/2013,2/4/2013,,31,NA,NA,NA,,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,1/5/2013,2/12/2013,2/8/2013,,35,2/8/2013,35,1,DAY,PARAESTHESIA,TINGLING,NA,PARAESTHESIA,NA,HLT_0481,NA,HLGT_0534,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,7/26/2013,10/13/2013,7/7/2013,,-19,7/26/2013,1,20,DAY,WHITE BLOOD CELL COUNT INCREASED,WBC INCREASED,NA,WHITE BLOOD CELL COUNT INCREASED,NA,HLT_0417,NA,HLGT_0465,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,7/26/2013,10/13/2013,7/7/2013,,-19,7/26/2013,1,20,DAY,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,NA,NEUTROPHIL COUNT INCREASED,NA,HLT_0326,NA,HLGT_0625,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,N,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,7/26/2013,10/13/2013,7/7/2013,,-19,7/24/2013,-2,18,DAY,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,NA,URINE ANALYSIS ABNORMAL,NA,HLT_0783,NA,HLGT_0295,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,N,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,7/26/2013,10/13/2013,7/7/2013,,-19,7/24/2013,-2,18,DAY,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,NA,URINE ANALYSIS ABNORMAL,NA,HLT_0783,NA,HLGT_0295,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,N,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,7/26/2013,10/13/2013,7/7/2013,,-19,7/26/2013,1,20,DAY,WHITE BLOOD CELL COUNT INCREASED,WBC INCREASED,NA,WHITE BLOOD CELL COUNT INCREASED,NA,HLT_0417,NA,HLGT_0465,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,N,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,7/26/2013,10/13/2013,7/7/2013,,-19,7/26/2013,1,20,DAY,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,NA,NEUTROPHIL COUNT INCREASED,NA,HLT_0326,NA,HLGT_0625,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,N,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,7/26/2013,10/13/2013,9/2/2013,,39,9/6/2013,43,5,DAY,RECTAL HAEMORRHAGE,RECTAL BLEEDING,NA,RECTAL HAEMORRHAGE,NA,HLT_0353,NA,HLGT_0755,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,Y,Y,Y,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,7/26/2013,10/13/2013,9/2/2013,,39,9/6/2013,43,5,DAY,RECTAL HAEMORRHAGE,RECTAL BLEEDING,NA,RECTAL HAEMORRHAGE,NA,HLT_0353,NA,HLGT_0755,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,7/26/2013,10/13/2013,9/9/2013,,46,9/24/2013,61,16,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,9,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1042,Placebo,0,64,<65,1,WHITE,1,M,Y,3/2/2013,8/31/2013,3/4/2013,,3,3/5/2013,4,2,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1042,Placebo,0,64,<65,1,WHITE,1,M,Y,3/2/2013,8/31/2013,3/5/2013,,4,3/6/2013,5,2,DAY,INSOMNIA,INSOMNIA,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,10/25/2013,12/24/2013,11/16/2013,,23,11/16/2013,23,1,DAY,BIOPSY PROSTATE,BIOPSY OF PROSTATE,NA,BIOPSY PROSTATE,NA,HLT_0553,NA,HLGT_0725,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,10/25/2013,12/24/2013,11/20/2013,,27,NA,NA,NA,,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERTROPHY,NA,BENIGN PROSTATIC HYPERPLASIA,NA,HLT_0215,NA,HLGT_0568,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,10/25/2013,12/24/2013,11/23/2013,,30,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,10/25/2013,12/24/2013,11/23/2013,,30,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,10/25/2013,12/24/2013,11/25/2013,,32,NA,NA,NA,,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,10/25/2013,12/24/2013,11/23/2013,,30,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,9/2/2012,12/4/2012,9/13/2012,,12,1/2/2013,123,112,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,9/2/2012,12/4/2012,9/13/2012,,12,1/2/2013,123,112,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,9/2/2012,12/4/2012,9/13/2012,,12,1/2/2013,123,112,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,9/2/2012,12/4/2012,10/9/2012,,38,10/15/2012,44,7,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,9/2/2012,12/4/2012,10/9/2012,,38,10/15/2012,44,7,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,9/2/2012,12/4/2012,9/13/2012,,12,1/2/2013,123,112,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,3/13/2013,9/14/2013,4/5/2013,,24,4/16/2013,35,12,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,3/13/2013,9/14/2013,4/5/2013,,24,4/16/2013,35,12,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,3/13/2013,9/14/2013,4/5/2013,,24,4/16/2013,35,12,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,3/13/2013,9/14/2013,4/25/2013,,44,4/25/2013,44,1,DAY,CATARACT OPERATION,CATARACT EXTRACTION,NA,CATARACT OPERATION,NA,HLT_0432,NA,HLGT_0058,NA,SURGICAL AND MEDICAL PROCEDURES,SURGICAL AND MEDICAL PROCEDURES,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,3/13/2013,9/14/2013,5/27/2013,,76,6/3/2013,83,8,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,3/13/2013,9/14/2013,2/28/2013,,-13,9/14/2013,186,199,DAY,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,6,N,,,,,,,,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,3/13/2013,9/14/2013,7/17/2013,,127,9/14/2013,186,60,DAY,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,3/13/2013,9/14/2013,2/28/2013,,-13,9/14/2013,186,199,DAY,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,N,,,,,,,,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,3/13/2013,9/14/2013,7/17/2013,,127,9/14/2013,186,60,DAY,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,703,01-703-1119,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2/20/2013,6/13/2013,3/16/2013,,25,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1119,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2/20/2013,6/13/2013,3/16/2013,,25,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1119,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2/20/2013,6/13/2013,5/4/2013,,74,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1119,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2/20/2013,6/13/2013,5/4/2013,,74,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1175,Placebo,0,75,65-80,2,WHITE,1,M,Y,12/20/2013,12/26/2013,12/18/2013,,-2,NA,NA,NA,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,HEART BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,703,01-703-1182,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,10/17/2013,12/11/2013,10/31/2013,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1182,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,10/17/2013,12/11/2013,10/31/2013,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1182,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,10/17/2013,12/11/2013,11/22/2013,,37,NA,NA,NA,,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1182,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,10/17/2013,12/11/2013,11/22/2013,,37,NA,NA,NA,,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,703,01-703-1210,Placebo,0,72,65-80,2,WHITE,1,F,Y,3/16/2013,9/6/2013,5/4/2013,,50,NA,NA,NA,,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1210,Placebo,0,72,65-80,2,WHITE,1,F,Y,3/16/2013,9/6/2013,5/4/2013,,50,NA,NA,NA,,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,7/20/2012,1/11/2013,8/11/2012,,23,8/19/2012,31,9,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,7/20/2012,1/11/2013,NA,,NA,NA,NA,NA,,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,N,,,,,,,,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,7/20/2012,1/11/2013,8/11/2012,,23,8/19/2012,31,9,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,7/20/2012,1/11/2013,9/4/2012,,47,1/25/2013,190,144,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,7/20/2012,1/11/2013,NA,,NA,NA,NA,NA,,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,N,,,,,,,,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,7/20/2012,1/11/2013,9/4/2012,,47,1/25/2013,190,144,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,7/20/2012,1/11/2013,9/4/2012,,47,1/25/2013,190,144,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,9/12/2012,3/13/2013,9/27/2012,,16,10/6/2012,25,10,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,9/12/2012,3/13/2013,9/27/2012,,16,10/6/2012,25,10,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,9/12/2012,3/13/2013,3/1/2013,,171,NA,NA,NA,,HYPOTENSION,HYPOTENSION,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,9/12/2012,3/13/2013,3/1/2013,,171,NA,NA,NA,,HYPOTENSION,HYPOTENSION,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,703,01-703-1335,Xanomeline High Dose,81,67,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,3/17/2014,5/7/2014,3/15/2014,,-2,3/30/2014,14,16,DAY,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,703,01-703-1335,Xanomeline High Dose,81,67,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,3/17/2014,5/7/2014,3/15/2014,,-2,3/30/2014,14,16,DAY,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,N,,,,,,,,
CDISCPILOT01,703,01-703-1403,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,12/12/2012,12/13/2012,12/12/2012,,1,12/19/2012,8,8,DAY,WEIGHT DECREASED,WEIGHT LOSS,NA,WEIGHT DECREASED,NA,HLT_0158,NA,HLGT_0778,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1403,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,12/12/2012,12/13/2012,12/13/2012,,2,12/14/2012,3,2,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1403,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,12/12/2012,12/13/2012,12/13/2012,,2,12/14/2012,3,2,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,703,01-703-1403,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,12/12/2012,12/13/2012,12/15/2012,,4,12/16/2012,5,2,DAY,CHEST DISCOMFORT,CHEST TIGHTNESS,NA,CHEST DISCOMFORT,NA,HLT_0593,NA,HLGT_0441,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1403,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,12/12/2012,12/13/2012,12/12/2012,,1,12/19/2012,8,8,DAY,WEIGHT DECREASED,WEIGHT LOSS,NA,WEIGHT DECREASED,NA,HLT_0158,NA,HLGT_0778,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,703,01-703-1439,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,3/12/2014,9/11/2014,4/24/2014,,44,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1439,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,3/12/2014,9/11/2014,4/24/2014,,44,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1008,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,1/13/2013,2/21/2013,1/30/2013,,18,NA,NA,NA,,HYPERHIDROSIS,SWEATING INCREASED,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1008,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,1/13/2013,2/21/2013,2/21/2013,,40,2/21/2013,40,1,DAY,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1008,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,1/13/2013,2/21/2013,2/25/2013,,44,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,8/27/2013,9/25/2013,9/5/2013,,10,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,8/27/2013,9/25/2013,9/5/2013,,10,9/27/2013,32,23,DAY,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,8/27/2013,9/25/2013,9/14/2013,,19,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,8/27/2013,9/25/2013,9/5/2013,,10,9/27/2013,32,23,DAY,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,8/27/2013,9/25/2013,9/17/2013,,22,NA,NA,NA,,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,8/27/2013,9/25/2013,9/22/2013,,27,9/23/2013,28,2,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2/21/2014,7/8/2014,2/27/2014,,7,3/6/2014,14,8,DAY,CYSTITIS,BLADDER INFECTION,NA,CYSTITIS,NA,HLT_0739,NA,HLGT_0129,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2/21/2014,7/8/2014,7/5/2014,,135,7/6/2014,136,2,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2/21/2014,7/8/2014,7/5/2014,,135,7/6/2014,136,2,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2/21/2014,7/8/2014,7/6/2014,,136,NA,NA,NA,,EXCORIATION,ABRASION NOS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2/21/2014,7/8/2014,7/6/2014,,136,NA,NA,NA,,SKIN LACERATION,SKIN TEAR,NA,SKIN LACERATION,NA,HLT_0075,NA,HLGT_0118,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2/21/2014,7/8/2014,7/6/2014,,136,NA,NA,NA,,CONTUSION,BRUISE OF HEAD,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,10/6/2013,11/18/2013,11/1/2013,,27,11/8/2013,34,8,DAY,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,10/6/2013,11/18/2013,11/1/2013,,27,NA,NA,NA,,CARDIAC DISORDER,CARDIAC DISORDER,NA,CARDIAC DISORDER,NA,HLT_0507,NA,HLGT_0126,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,10/6/2013,11/18/2013,11/5/2013,,31,11/22/2013,48,18,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,10/6/2013,11/18/2013,11/5/2013,,31,11/22/2013,48,18,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,10/6/2013,11/18/2013,11/5/2013,,31,11/22/2013,48,18,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,10/6/2013,11/18/2013,11/5/2013,,31,11/22/2013,48,18,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/27/2013,10/24/2013,9/28/2013,,2,9/30/2013,4,3,DAY,VERTIGO,VERTIGO,NA,VERTIGO,NA,HLT_0255,NA,HLGT_0147,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/27/2013,10/24/2013,9/28/2013,,2,9/30/2013,4,3,DAY,PALPITATIONS,PALPITATIONS,NA,PALPITATIONS,NA,HLT_0493,NA,HLGT_0593,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/27/2013,10/24/2013,10/11/2013,,15,10/25/2013,29,15,DAY,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/27/2013,10/24/2013,10/25/2013,,29,11/29/2013,64,36,DAY,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,NA,WOLFF-PARKINSON-WHITE SYNDROME,NA,HLT_0612,NA,HLGT_0218,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/27/2013,10/24/2013,10/11/2013,,15,10/25/2013,29,15,DAY,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,9/27/2013,10/24/2013,10/25/2013,,29,11/29/2013,64,36,DAY,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,NA,WOLFF-PARKINSON-WHITE SYNDROME,NA,HLT_0612,NA,HLGT_0218,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,10/24/2013,12/22/2013,10/27/2013,,4,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,10/24/2013,12/22/2013,10/27/2013,,4,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,10/24/2013,12/22/2013,11/9/2013,,17,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,10/24/2013,12/22/2013,11/9/2013,,17,NA,NA,NA,,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,10/24/2013,12/22/2013,11/9/2013,,17,NA,NA,NA,,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,10/24/2013,12/22/2013,11/17/2013,,25,11/17/2013,25,1,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,10/24/2013,12/22/2013,11/17/2013,,25,11/17/2013,25,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,10/24/2013,12/22/2013,12/15/2013,,53,12/15/2013,53,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,10/24/2013,12/22/2013,12/24/2013,,62,NA,NA,NA,,SINUS BRADYCARDIA,BRADYCARDIA SINUS,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,10,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1074,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,1/22/2014,3/20/2014,1/22/2014,,1,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1074,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,1/22/2014,3/20/2014,2/9/2014,,19,NA,NA,NA,,ERYTHEMA,SKIN RED,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1093,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,3/15/2013,6/17/2013,3/30/2013,,16,4/13/2013,30,15,DAY,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,NA,BLOOD GLUCOSE INCREASED,NA,HLT_0450,NA,HLGT_0188,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1093,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,3/15/2013,6/17/2013,3/30/2013,,16,4/13/2013,30,15,DAY,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,NA,BLOOD GLUCOSE INCREASED,NA,HLT_0450,NA,HLGT_0188,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,704,01-704-1093,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,3/15/2013,6/17/2013,5/4/2013,,51,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1093,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,3/15/2013,6/17/2013,5/4/2013,,51,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1114,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,1/23/2013,7/7/2013,2/21/2013,,30,2/23/2013,32,3,DAY,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1114,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,1/23/2013,7/7/2013,3/23/2013,,60,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1114,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,1/23/2013,7/7/2013,3/23/2013,,60,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1114,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,1/23/2013,7/7/2013,6/7/2013,,136,6/13/2013,142,7,DAY,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,12/2/2013,2/1/2014,12/23/2013,,22,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,12/2/2013,2/1/2014,12/28/2013,,27,2/3/2014,64,38,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,12/2/2013,2/1/2014,12/23/2013,,22,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,12/2/2013,2/1/2014,1/27/2014,,57,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,12/2/2013,2/1/2014,1/27/2014,,57,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,12/2/2013,2/1/2014,12/28/2013,,27,2/3/2014,64,38,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,704,01-704-1135,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,10/31/2013,5/16/2014,12/8/2013,,39,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1135,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,10/31/2013,5/16/2014,12/8/2013,,39,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1164,Placebo,0,67,65-80,2,WHITE,1,F,Y,9/19/2012,4/4/2013,9/27/2012,,9,10/7/2012,19,11,DAY,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1164,Placebo,0,67,65-80,2,WHITE,1,F,Y,9/19/2012,4/4/2013,9/27/2012,,9,10/7/2012,19,11,DAY,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,704,01-704-1164,Placebo,0,67,65-80,2,WHITE,1,F,Y,9/19/2012,4/4/2013,2/4/2013,,139,2/13/2013,148,10,DAY,OEDEMA PERIPHERAL,SWELLING OF FEET,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1218,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,11/19/2012,5/27/2013,12/30/2012,,42,NA,NA,NA,,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,NA,BLOOD GLUCOSE INCREASED,NA,HLT_0450,NA,HLGT_0188,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1241,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,8/25/2013,10/9/2013,8/14/2013,,-11,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1241,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,8/25/2013,10/9/2013,9/28/2013,,35,NA,NA,NA,,DYSPNOEA,RESPIRATION LABORED,NA,DYSPNOEA,NA,HLT_0296,NA,HLGT_0255,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,10/17/2013,,5,12/23/2013,72,68,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,10/27/2013,,15,11/8/2013,27,13,DAY,ATRIAL FLUTTER,ATRIAL FLUTTER,NA,ATRIAL FLUTTER,NA,HLT_0477,NA,HLGT_0627,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,11/8/2013,,27,12/6/2013,55,29,DAY,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,10/27/2013,,15,11/8/2013,27,13,DAY,ATRIAL FLUTTER,ATRIAL FLUTTER,NA,ATRIAL FLUTTER,NA,HLT_0477,NA,HLGT_0627,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,11/9/2013,,28,12/4/2013,53,26,DAY,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,11/15/2013,,34,12/14/2013,63,30,DAY,BLISTER,BLISTERING,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,11/15/2013,,34,12/23/2013,72,39,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,10/17/2013,,5,12/23/2013,72,68,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,11/9/2013,,28,12/4/2013,53,26,DAY,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,10,Y,,,,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,12/6/2013,,55,12/23/2013,72,18,DAY,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,10/17/2013,,5,12/23/2013,72,68,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,12,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,11/8/2013,,27,12/6/2013,55,29,DAY,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,13,Y,,,,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,11/15/2013,,34,12/14/2013,63,30,DAY,BLISTER,BLISTERING,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,14,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,11/15/2013,,34,12/23/2013,72,39,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,15,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,10/13/2013,12/6/2013,12/6/2013,,55,12/23/2013,72,18,DAY,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,16,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1323,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,F,Y,7/8/2013,8/5/2013,7/30/2013,,23,8/3/2013,27,5,DAY,VIRAL INFECTION,VIRAL INFECTION,NA,VIRAL INFECTION,NA,HLT_0733,NA,HLGT_0408,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1323,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,F,Y,7/8/2013,8/5/2013,8/4/2013,,28,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1323,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,F,Y,7/8/2013,8/5/2013,8/4/2013,,28,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1325,Xanomeline Low Dose,54,81,>80,3,WHITE,1,M,Y,4/23/2014,7/4/2014,5/23/2014,,31,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1325,Xanomeline Low Dose,54,81,>80,3,WHITE,1,M,Y,4/23/2014,7/4/2014,7/4/2014,,73,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,12/9/2013,2/14/2014,12/10/2013,,2,2/24/2014,78,77,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,12/9/2013,2/14/2014,1/18/2014,,41,2/24/2014,78,38,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,12/9/2013,2/14/2014,12/10/2013,,2,2/24/2014,78,77,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,12/9/2013,2/14/2014,2/3/2014,,57,NA,NA,NA,,BURNING SENSATION,BURNING SENSATION,NA,BURNING SENSATION,NA,HLT_0775,NA,HLGT_0456,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,12/9/2013,2/14/2014,12/10/2013,,2,2/24/2014,78,77,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,12/9/2013,2/14/2014,1/18/2014,,41,2/24/2014,78,38,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1351,Placebo,0,70,65-80,2,WHITE,1,M,Y,10/12/2013,4/18/2014,10/27/2013,,16,4/4/2014,175,160,DAY,POLLAKIURIA,URINARY FREQUENCY,NA,POLLAKIURIA,NA,HLT_0393,NA,HLGT_0560,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1351,Placebo,0,70,65-80,2,WHITE,1,M,Y,10/12/2013,4/18/2014,10/27/2013,,16,4/4/2014,175,160,DAY,FLATULENCE,GAS,NA,FLATULENCE,NA,HLT_0356,NA,HLGT_0504,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1351,Placebo,0,70,65-80,2,WHITE,1,M,Y,10/12/2013,4/18/2014,10/27/2013,,16,4/4/2014,175,160,DAY,POLLAKIURIA,URINARY FREQUENCY,NA,POLLAKIURIA,NA,HLT_0393,NA,HLGT_0560,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,704,01-704-1351,Placebo,0,70,65-80,2,WHITE,1,M,Y,10/12/2013,4/18/2014,10/27/2013,,16,4/4/2014,175,160,DAY,FLATULENCE,GAS,NA,FLATULENCE,NA,HLT_0356,NA,HLGT_0504,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,704,01-704-1388,Placebo,0,81,>80,3,WHITE,1,M,Y,12/7/2012,6/11/2013,8/23/2012,,-106,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,704,01-704-1445,Placebo,0,75,65-80,2,WHITE,1,M,Y,5/11/2014,11/1/2014,10/31/2014,,174,10/31/2014,174,1,DAY,COMPLETED SUICIDE,SUICIDE,NA,COMPLETED SUICIDE,NA,HLT_0625,NA,HLGT_0013,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,SEVERE,N,N,N,N,Y,N,N,N,NONE,,FATAL,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,705,01-705-1031,Xanomeline Low Dose,54,56,<65,1,WHITE,1,F,Y,11/27/2013,5/11/2014,12/25/2013,,29,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1059,Placebo,0,66,65-80,2,WHITE,1,F,Y,8/5/2013,12/5/2013,11/2/2013,,90,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1199,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,9/16/2013,9/28/2013,9/17/2013,,2,9/29/2013,14,13,DAY,DYSPEPSIA,PYROSIS,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,705,01-705-1199,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,9/16/2013,9/28/2013,9/17/2013,,2,9/29/2013,14,13,DAY,DYSPEPSIA,PYROSIS,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,705,01-705-1280,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,1/17/2014,7/25/2014,4/20/2014,,94,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1281,Xanomeline High Dose,81,73,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,11/28/2013,2/27/2014,1/30/2014,,64,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1281,Xanomeline High Dose,81,73,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,11/28/2013,2/27/2014,1/30/2014,,64,NA,NA,NA,,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,705,01-705-1281,Xanomeline High Dose,81,73,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,11/28/2013,2/27/2014,1/30/2014,,64,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1292,Xanomeline Low Dose,54,60,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,10/14/2013,5/13/2014,10/28/2013,,15,NA,NA,NA,,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1292,Xanomeline Low Dose,54,60,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,10/14/2013,5/13/2014,2/13/2014,,123,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1303,Xanomeline High Dose,81,72,65-80,2,WHITE,1,M,Y,12/16/2013,6/2/2014,2/5/2014,,52,3/3/2014,78,27,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1303,Xanomeline High Dose,81,72,65-80,2,WHITE,1,M,Y,12/16/2013,6/2/2014,2/5/2014,,52,3/3/2014,78,27,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1303,Xanomeline High Dose,81,72,65-80,2,WHITE,1,M,Y,12/16/2013,6/2/2014,2/5/2014,,52,3/3/2014,78,27,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1303,Xanomeline High Dose,81,72,65-80,2,WHITE,1,M,Y,12/16/2013,6/2/2014,2/5/2014,,52,3/3/2014,78,27,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1310,Xanomeline High Dose,81,74,65-80,2,WHITE,1,F,Y,11/2/2013,1/23/2014,11/14/2013,,13,NA,NA,NA,,RASH PRURITIC,PRURITIC RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1349,Placebo,0,86,>80,3,WHITE,1,F,Y,3/10/2013,9/8/2013,4/8/2013,,30,4/8/2013,30,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,705,01-705-1349,Placebo,0,86,>80,3,WHITE,1,F,Y,3/10/2013,9/8/2013,4/11/2013,,33,4/11/2013,33,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,705,01-705-1349,Placebo,0,86,>80,3,WHITE,1,F,Y,3/10/2013,9/8/2013,8/25/2013,,169,NA,NA,NA,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,705,01-705-1393,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,9/7/2012,2/1/2013,9/19/2012,,13,9/24/2012,18,6,DAY,ABDOMINAL PAIN,ABDOMINAL CRAMPS,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,705,01-705-1393,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,9/7/2012,2/1/2013,12/5/2011,,-277,2/20/2013,167,444,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1393,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,9/7/2012,2/1/2013,1/21/2013,,137,1/24/2013,140,4,DAY,COLON CANCER,COLON CANCER,NA,COLON CANCER,NA,HLT_0597,NA,HLGT_0339,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",NA,SEVERE,N,Y,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,705,01-705-1393,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,9/7/2012,2/1/2013,12/5/2011,,-277,2/20/2013,167,444,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1431,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,F,Y,6/23/2013,12/19/2013,7/4/2013,,12,7/6/2013,14,3,DAY,ANXIETY,FEELING ANXIOUS,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,12/31/2013,7/28/2014,5/1/2012,D,-609,NA,NA,NA,,ANXIETY,ANXIETY ATTACK,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,12/31/2013,7/28/2014,1/7/2014,,8,1/8/2014,9,2,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,12/31/2013,7/28/2014,1/14/2014,,15,1/28/2014,29,15,DAY,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,12/31/2013,7/28/2014,1/15/2014,,16,7/29/2014,211,196,DAY,IRRITABILITY,IRRITABILITY,NA,IRRITABILITY,NA,HLT_0627,NA,HLGT_0461,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,12/31/2013,7/28/2014,1/14/2014,,15,1/28/2014,29,15,DAY,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,12/31/2013,7/28/2014,3/4/2014,,64,7/29/2014,211,148,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,12/31/2013,7/28/2014,5/1/2012,D,-609,NA,NA,NA,,ANXIETY,ANXIETY ATTACK,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,N,,,,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,12/31/2013,7/28/2014,1/15/2014,,16,7/29/2014,211,196,DAY,IRRITABILITY,IRRITABILITY,NA,IRRITABILITY,NA,HLT_0627,NA,HLGT_0461,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,12/31/2013,7/28/2014,3/4/2014,,64,7/29/2014,211,148,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,9,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1049,Xanomeline High Dose,81,60,<65,1,WHITE,1,F,Y,5/14/2013,6/18/2013,6/3/2013,,21,6/3/2013,21,1,DAY,SYNCOPE,FAINTING,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,706,01-706-1049,Xanomeline High Dose,81,60,<65,1,WHITE,1,F,Y,5/14/2013,6/18/2013,6/18/2013,,36,6/18/2013,36,1,DAY,SYNCOPE,SYNCOPAL ATTACK,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,9/15/2012,9/24/2012,9/15/2012,,1,9/29/2012,15,15,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,9/15/2012,9/24/2012,9/15/2012,,1,9/29/2012,15,15,DAY,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,9/15/2012,9/24/2012,9/15/2012,,1,9/29/2012,15,15,DAY,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,9/15/2012,9/24/2012,9/23/2012,,9,9/29/2012,15,7,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,9/15/2012,9/24/2012,9/23/2012,,9,9/29/2012,15,7,DAY,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,9/15/2012,9/24/2012,9/15/2012,,1,9/29/2012,15,15,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,9/15/2012,9/24/2012,9/15/2012,,1,9/29/2012,15,15,DAY,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,9/15/2012,9/24/2012,9/15/2012,,1,9/29/2012,15,15,DAY,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,9/15/2012,9/24/2012,9/23/2012,,9,9/29/2012,15,7,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,9,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,9/15/2012,9/24/2012,9/23/2012,,9,9/29/2012,15,7,DAY,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,10,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,10/28/2013,4/26/2014,11/25/2013,,29,12/23/2013,57,29,DAY,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,NA,SINUS ARRHYTHMIA,NA,HLT_0094,NA,HLGT_0630,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,10/28/2013,4/26/2014,11/26/2013,,30,12/9/2013,43,14,DAY,BLOOD CREATINE PHOSPHOKINASE INCREASED,CPK INCREASE,NA,BLOOD CREATINE PHOSPHOKINASE INCREASED,NA,HLT_0404,NA,HLGT_0008,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,10/28/2013,4/26/2014,12/3/2013,,37,12/10/2013,44,8,DAY,POSTNASAL DRIP,POSTNASAL DRIP,NA,POSTNASAL DRIP,NA,HLT_0172,NA,HLGT_0032,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,10/28/2013,4/26/2014,11/26/2013,,30,12/9/2013,43,14,DAY,BLOOD CREATINE PHOSPHOKINASE INCREASED,CPK INCREASE,NA,BLOOD CREATINE PHOSPHOKINASE INCREASED,NA,HLT_0404,NA,HLGT_0008,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,10/28/2013,4/26/2014,12/3/2013,,37,12/10/2013,44,8,DAY,POSTNASAL DRIP,POSTNASAL DRIP,NA,POSTNASAL DRIP,NA,HLT_0172,NA,HLGT_0032,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,10/28/2013,4/26/2014,11/25/2013,,29,12/23/2013,57,29,DAY,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,NA,SINUS ARRHYTHMIA,NA,HLT_0094,NA,HLGT_0630,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,10/28/2013,4/26/2014,2/8/2014,,104,2/22/2014,118,15,DAY,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,EYE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,10/28/2013,4/26/2014,2/8/2014,,104,2/22/2014,118,15,DAY,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,EYE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,708,01-708-1019,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,12/20/2013,1/1/2014,12/31/2013,,12,12/31/2013,12,1,DAY,HEADACHE,FRONTAL HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1019,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,12/20/2013,1/1/2014,1/1/2014,,13,1/1/2014,13,1,DAY,STUPOR,STUPOR,NA,STUPOR,NA,HLT_0595,NA,HLGT_0513,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1019,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,12/20/2013,1/1/2014,1/1/2014,,13,1/1/2014,13,1,DAY,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1019,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,12/20/2013,1/1/2014,1/1/2014,,13,1/1/2014,13,1,DAY,VISION BLURRED,BLURRED VISION,NA,VISION BLURRED,NA,HLT_0120,NA,HLGT_0598,NA,EYE DISORDERS,EYE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1019,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,12/20/2013,1/1/2014,1/1/2014,,13,1/1/2014,13,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1032,Xanomeline Low Dose,54,62,<65,1,WHITE,1,M,Y,2/9/2013,3/1/2013,2/26/2013,,18,3/9/2013,29,12,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1084,Xanomeline Low Dose,54,73,65-80,2,WHITE,1,F,Y,5/9/2013,11/11/2013,5/23/2013,,15,5/23/2013,15,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1084,Xanomeline Low Dose,54,73,65-80,2,WHITE,1,F,Y,5/9/2013,11/11/2013,5/23/2013,,15,5/23/2013,15,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1084,Xanomeline Low Dose,54,73,65-80,2,WHITE,1,F,Y,5/9/2013,11/11/2013,6/23/2013,,46,6/23/2013,46,1,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1084,Xanomeline Low Dose,54,73,65-80,2,WHITE,1,F,Y,5/9/2013,11/11/2013,6/23/2013,,46,6/23/2013,46,1,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,10/22/2012,4/28/2013,1/19/2013,,90,1/19/2013,90,1,DAY,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,10/22/2012,4/28/2013,1/19/2013,,90,1/19/2013,90,1,DAY,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,10/22/2012,4/28/2013,2/4/2013,,106,2/8/2013,110,5,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,10/22/2012,4/28/2013,2/16/2013,,118,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,10/22/2012,4/28/2013,3/16/2013,,146,3/16/2013,146,1,DAY,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,10/22/2012,4/28/2013,3/16/2013,,146,3/16/2013,146,1,DAY,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,708,01-708-1158,Placebo,0,81,>80,3,WHITE,1,F,Y,2/8/2014,3/21/2014,2/25/2014,,18,NA,NA,NA,,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1158,Placebo,0,81,>80,3,WHITE,1,F,Y,2/8/2014,3/21/2014,3/22/2014,,43,3/22/2014,43,1,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/29/2013,4/6/2014,12/19/2013,,-10,NA,NA,NA,,FLANK PAIN,FLANK PAIN,NA,FLANK PAIN,NA,HLT_0484,NA,HLGT_0543,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/29/2013,4/6/2014,3/1/2014,,63,3/8/2014,70,8,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/29/2013,4/6/2014,3/9/2014,,71,4/6/2014,99,29,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/29/2013,4/6/2014,3/9/2014,,71,4/6/2014,99,29,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/29/2013,4/6/2014,3/24/2014,,86,3/26/2014,88,3,DAY,DIZZINESS,LIGHT-HEADED,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/29/2013,4/6/2014,3/24/2014,,86,3/26/2014,88,3,DAY,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/29/2013,4/6/2014,3/24/2014,,86,3/28/2014,90,5,DAY,CYSTITIS,BLADDER INFECTION,NA,CYSTITIS,NA,HLT_0739,NA,HLGT_0129,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/29/2013,4/6/2014,3/24/2014,,86,3/24/2014,86,1,DAY,ALCOHOL USE,ALCOHOL USE,NA,ALCOHOL USE,NA,HLT_0138,NA,HLGT_0182,NA,SOCIAL CIRCUMSTANCES,SOCIAL CIRCUMSTANCES,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1213,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2/9/2013,2/22/2013,2/22/2013,,14,2/22/2013,14,1,DAY,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1213,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2/9/2013,2/22/2013,2/22/2013,,14,2/22/2013,14,1,DAY,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1216,Xanomeline High Dose,81,78,65-80,2,WHITE,1,M,Y,10/24/2012,11/29/2012,11/6/2012,,14,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1216,Xanomeline High Dose,81,78,65-80,2,WHITE,1,M,Y,10/24/2012,11/29/2012,11/6/2012,,14,12/13/2012,51,38,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1216,Xanomeline High Dose,81,78,65-80,2,WHITE,1,M,Y,10/24/2012,11/29/2012,11/22/2012,,30,NA,NA,NA,,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1216,Xanomeline High Dose,81,78,65-80,2,WHITE,1,M,Y,10/24/2012,11/29/2012,11/6/2012,,14,12/13/2012,51,38,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,5/7/2013,11/5/2013,5/6/2013,,-1,5/16/2013,10,11,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,5/7/2013,11/5/2013,5/6/2013,,-1,5/16/2013,10,11,DAY,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,EYE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,N,,,,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,5/7/2013,11/5/2013,5/7/2013,,1,5/10/2013,4,4,DAY,HEART RATE INCREASED,HEART RATE INCREASED,NA,HEART RATE INCREASED,NA,HLT_0646,NA,HLGT_0673,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,5/7/2013,11/5/2013,5/6/2013,,-1,5/16/2013,10,11,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,N,,,,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,5/7/2013,11/5/2013,5/6/2013,,-1,5/16/2013,10,11,DAY,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,EYE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,N,,,,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,5/7/2013,11/5/2013,5/7/2013,,1,5/10/2013,4,4,DAY,HEART RATE INCREASED,HEART RATE INCREASED,NA,HEART RATE INCREASED,NA,HLT_0646,NA,HLGT_0673,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,5/7/2013,11/5/2013,6/7/2013,,32,6/7/2013,32,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,5/7/2013,11/5/2013,6/7/2013,,32,6/7/2013,32,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,2/11/2013,,6,2/11/2013,6,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,2/18/2013,,13,2/18/2013,13,1,DAY,MUSCLE SPASMS,LEG CRAMPS,NA,MUSCLE SPASMS,NA,HLT_0078,NA,HLGT_0750,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,2/21/2013,,16,3/20/2013,43,28,DAY,VENTRICULAR EXTRASYSTOLES,VENTRICULAR BIGEMINY,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,2/27/2013,,22,2/27/2013,22,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,3/1/2013,,24,3/7/2013,30,7,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,3/1/2013,,24,3/7/2013,30,7,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,3/7/2013,,30,3/7/2013,30,1,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,3/1/2013,,24,3/7/2013,30,7,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,3/1/2013,,24,3/7/2013,30,7,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,3/7/2013,,30,3/7/2013,30,1,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,10,Y,,,,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,3/19/2013,,42,3/19/2013,42,1,DAY,HOT FLUSH,HOT FLASHES,NA,HOT FLUSH,NA,HLT_0737,NA,HLGT_0773,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,11,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2/6/2013,3/22/2013,2/21/2013,,16,3/20/2013,43,28,DAY,VENTRICULAR EXTRASYSTOLES,VENTRICULAR BIGEMINY,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,12,Y,,,,,,,,
CDISCPILOT01,708,01-708-1286,Placebo,0,80,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,9/10/2013,3/8/2014,9/12/2013,,3,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1286,Placebo,0,80,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,9/10/2013,3/8/2014,2/18/2014,,162,2/18/2014,162,1,DAY,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1286,Placebo,0,80,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,9/10/2013,3/8/2014,2/18/2014,,162,2/18/2014,162,1,DAY,CONSTIPATION,CONSTIPATION,NA,CONSTIPATION,NA,HLT_0402,NA,HLGT_0635,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,6/14/2013,12/12/2013,6/27/2013,,14,6/27/2013,14,1,DAY,ATRIAL HYPERTROPHY,LEFT ATRIAL HYPERTROPHY,NA,ATRIAL HYPERTROPHY,NA,HLT_0271,NA,HLGT_0067,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,6/14/2013,12/12/2013,6/27/2013,,14,6/27/2013,14,1,DAY,ATRIAL HYPERTROPHY,LEFT ATRIAL HYPERTROPHY,NA,ATRIAL HYPERTROPHY,NA,HLT_0271,NA,HLGT_0067,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,6/14/2013,12/12/2013,9/4/2013,,83,9/18/2013,97,15,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,6/14/2013,12/12/2013,9/4/2013,,83,9/18/2013,97,15,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,6/14/2013,12/12/2013,10/4/2013,,113,10/30/2013,139,27,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,6/14/2013,12/12/2013,10/4/2013,,113,10/30/2013,139,27,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,6/14/2013,12/12/2013,12/7/2013,,177,12/7/2013,177,1,DAY,PAIN IN EXTREMITY,PAIN IN THIGH,NA,PAIN IN EXTREMITY,NA,HLT_0213,NA,HLGT_0764,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1297,Xanomeline Low Dose,54,61,<65,1,WHITE,1,M,Y,1/25/2013,5/3/2013,4/2/2013,,68,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1297,Xanomeline Low Dose,54,61,<65,1,WHITE,1,M,Y,1/25/2013,5/3/2013,4/2/2013,,68,NA,NA,NA,,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1297,Xanomeline Low Dose,54,61,<65,1,WHITE,1,M,Y,1/25/2013,5/3/2013,5/8/2013,,104,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1316,Placebo,0,74,65-80,2,WHITE,1,F,Y,8/23/2013,3/1/2014,1/29/2014,,160,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1316,Placebo,0,74,65-80,2,WHITE,1,F,Y,8/23/2013,3/1/2014,2/15/2014,,177,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,12/7/2012,6/5/2013,12/18/2012,,12,12/18/2012,12,1,DAY,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,12/7/2012,6/5/2013,1/12/2013,,37,1/12/2013,37,1,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,12/7/2012,6/5/2013,2/2/2013,,58,2/2/2013,58,1,DAY,DIZZINESS,LIGHT HEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,12/7/2012,6/5/2013,4/10/2013,,125,6/5/2013,181,57,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,12/7/2012,6/5/2013,4/10/2013,,125,6/5/2013,181,57,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,12/7/2012,6/5/2013,4/10/2013,,125,6/5/2013,181,57,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,12/7/2012,6/5/2013,4/10/2013,,125,6/5/2013,181,57,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,4/20/2013,6/18/2013,6/13/2013,,55,6/25/2013,67,13,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,4/20/2013,6/18/2013,6/13/2013,,55,6/25/2013,67,13,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,4/20/2013,6/18/2013,6/13/2013,,55,6/25/2013,67,13,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,4/20/2013,6/18/2013,6/13/2013,,55,6/25/2013,67,13,DAY,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,4/20/2013,6/18/2013,6/13/2013,,55,6/25/2013,67,13,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,4/20/2013,6/18/2013,6/13/2013,,55,6/25/2013,67,13,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,4/20/2013,6/18/2013,6/13/2013,,55,6/25/2013,67,13,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,4/20/2013,6/18/2013,6/13/2013,,55,6/25/2013,67,13,DAY,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1348,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,8/5/2013,2/13/2014,12/1/2013,,119,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1353,Xanomeline Low Dose,54,87,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,7/4/2013,8/28/2013,8/18/2013,,46,9/10/2013,69,24,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1353,Xanomeline Low Dose,54,87,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,7/4/2013,8/28/2013,8/18/2013,,46,9/10/2013,69,24,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1353,Xanomeline Low Dose,54,87,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,7/4/2013,8/28/2013,8/28/2013,,56,9/10/2013,69,14,DAY,HYPOTENSION,LOW BLOOD PRESSURE,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1372,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,4/12/2013,4/19/2013,4/10/2013,,-2,NA,NA,NA,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,708,01-708-1406,Xanomeline High Dose,81,71,65-80,2,WHITE,1,F,Y,12/26/2013,7/2/2014,6/16/2014,,173,NA,NA,NA,,OEDEMA PERIPHERAL,SWELLING OF LEGS,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1406,Xanomeline High Dose,81,71,65-80,2,WHITE,1,F,Y,12/26/2013,7/2/2014,6/16/2014,,173,NA,NA,NA,,OEDEMA PERIPHERAL,SWELLING OF LEGS,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,11/9/2013,12/14/2013,11/22/2013,,14,11/22/2013,14,1,DAY,EPISTAXIS,NOSE BLEED,NA,EPISTAXIS,NA,HLT_0386,NA,HLGT_0577,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,11/9/2013,12/14/2013,12/10/2013,,32,12/21/2013,43,12,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,11/9/2013,12/14/2013,12/10/2013,,32,12/21/2013,43,12,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,11/9/2013,12/14/2013,12/10/2013,,32,12/21/2013,43,12,DAY,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,NA,APPLICATION SITE WARMTH,NA,HLT_0260,NA,HLGT_0301,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,11/9/2013,12/14/2013,12/10/2013,,32,12/21/2013,43,12,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,11/9/2013,12/14/2013,12/10/2013,,32,12/21/2013,43,12,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,11/9/2013,12/14/2013,12/10/2013,,32,12/21/2013,43,12,DAY,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,NA,APPLICATION SITE WARMTH,NA,HLT_0260,NA,HLGT_0301,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1007,Xanomeline Low Dose,54,54,<65,1,WHITE,1,F,Y,7/31/2012,8/28/2012,8/16/2012,,17,8/19/2012,20,4,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1007,Xanomeline Low Dose,54,54,<65,1,WHITE,1,F,Y,7/31/2012,8/28/2012,8/16/2012,,17,8/19/2012,20,4,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1007,Xanomeline Low Dose,54,54,<65,1,WHITE,1,F,Y,7/31/2012,8/28/2012,8/21/2012,,22,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1007,Xanomeline Low Dose,54,54,<65,1,WHITE,1,F,Y,7/31/2012,8/28/2012,8/30/2012,,31,8/30/2012,31,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1020,Xanomeline Low Dose,54,72,65-80,2,WHITE,1,F,Y,12/1/2012,6/1/2013,12/27/2012,,27,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1020,Xanomeline Low Dose,54,72,65-80,2,WHITE,1,F,Y,12/1/2012,6/1/2013,1/3/2013,,34,1/11/2013,42,9,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1020,Xanomeline Low Dose,54,72,65-80,2,WHITE,1,F,Y,12/1/2012,6/1/2013,1/3/2013,,34,1/11/2013,42,9,DAY,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1020,Xanomeline Low Dose,54,72,65-80,2,WHITE,1,F,Y,12/1/2012,6/1/2013,1/15/2013,,46,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,12/25/2012,6/26/2013,1/17/2013,,24,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,12/25/2012,6/26/2013,1/24/2013,,31,2/27/2013,65,35,DAY,MUSCLE SPASMS,CRAMP,NA,MUSCLE SPASMS,NA,HLT_0078,NA,HLGT_0750,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,12/25/2012,6/26/2013,1/24/2013,,31,2/27/2013,65,35,DAY,MUSCLE SPASMS,CRAMP,NA,MUSCLE SPASMS,NA,HLT_0078,NA,HLGT_0750,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,12/25/2012,6/26/2013,3/20/2013,,86,4/16/2013,113,28,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,12/25/2012,6/26/2013,3/20/2013,,86,4/16/2013,113,28,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,12/25/2012,6/26/2013,5/12/2013,,139,5/19/2013,146,8,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,10,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,12/25/2012,6/26/2013,5/12/2013,,139,5/19/2013,146,8,DAY,PHARYNGEAL ERYTHEMA,RED THROAT,NA,PHARYNGEAL ERYTHEMA,NA,HLT_0591,NA,HLGT_0398,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,12/25/2012,6/26/2013,5/12/2013,,139,5/19/2013,146,8,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,13,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,12/25/2012,6/26/2013,5/12/2013,,139,5/19/2013,146,8,DAY,PHARYNGEAL ERYTHEMA,RED THROAT,NA,PHARYNGEAL ERYTHEMA,NA,HLT_0591,NA,HLGT_0398,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,14,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,12/25/2012,6/26/2013,6/12/2013,,170,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,15,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,12/25/2012,6/26/2013,6/19/2013,,177,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,16,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1081,Xanomeline Low Dose,54,86,>80,3,WHITE,1,F,Y,1/18/2014,4/27/2014,4/7/2014,,80,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1081,Xanomeline Low Dose,54,86,>80,3,WHITE,1,F,Y,1/18/2014,4/27/2014,5/1/2014,,104,NA,NA,NA,,OEDEMA PERIPHERAL,PERIPHERAL SWELLING,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1088,Placebo,0,69,65-80,2,WHITE,1,M,Y,4/12/2014,10/9/2014,5/8/2014,,27,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1088,Placebo,0,69,65-80,2,WHITE,1,M,Y,4/12/2014,10/9/2014,8/2/2014,,113,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,10/25/2013,4/25/2014,11/6/2013,,13,11/17/2013,24,12,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,10/25/2013,4/25/2014,11/12/2013,,19,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,10/25/2013,4/25/2014,11/12/2013,,19,NA,NA,NA,,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,10/25/2013,4/25/2014,11/12/2013,,19,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,10/25/2013,4/25/2014,11/6/2013,,13,11/17/2013,24,12,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,10/25/2013,4/25/2014,11/12/2013,,19,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,10/25/2013,4/25/2014,11/12/2013,,19,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,10/25/2013,4/25/2014,3/23/2014,,150,3/23/2014,150,1,DAY,ACROCHORDON EXCISION,SKIN TAG REMOVAL,NA,ACROCHORDON EXCISION,NA,HLT_0629,NA,HLGT_0103,NA,SURGICAL AND MEDICAL PROCEDURES,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,1/15/2013,3/27/2013,2/11/2013,,28,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,1/15/2013,3/27/2013,2/11/2013,,28,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,1/15/2013,3/27/2013,2/11/2013,,28,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,1/15/2013,3/27/2013,2/11/2013,,28,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,1/15/2013,3/27/2013,3/20/2013,,65,3/26/2013,71,7,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,1/15/2013,3/27/2013,3/26/2013,,71,3/27/2013,72,2,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1168,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,8/2/2013,9/26/2013,9/6/2013,,36,10/11/2013,71,36,DAY,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1168,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,8/2/2013,9/26/2013,9/6/2013,,36,10/11/2013,71,36,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1168,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,8/2/2013,9/26/2013,9/6/2013,,36,10/11/2013,71,36,DAY,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1168,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,8/2/2013,9/26/2013,9/6/2013,,36,10/11/2013,71,36,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,3/4/2013,6/11/2013,3/6/2013,,3,3/6/2013,3,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,3/4/2013,6/11/2013,3/20/2013,,17,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,3/4/2013,6/11/2013,3/26/2013,,23,6/18/2013,107,85,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,3/4/2013,6/11/2013,3/27/2013,,24,3/27/2013,24,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,3/4/2013,6/11/2013,3/30/2013,,27,NA,NA,NA,,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,3/4/2013,6/11/2013,4/1/2013,,29,4/11/2013,39,11,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,3/4/2013,6/11/2013,4/1/2013,,29,4/11/2013,39,11,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,3/4/2013,6/11/2013,3/26/2013,,23,6/18/2013,107,85,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,3/4/2013,6/11/2013,5/17/2013,,75,5/18/2013,76,2,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,3/4/2013,6/11/2013,3/26/2013,,23,6/18/2013,107,85,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,10,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,3/4/2013,6/11/2013,5/27/2013,,85,6/18/2013,107,23,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,11,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,5/15/2013,8/6/2013,5/28/2013,,14,5/28/2013,14,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,5/15/2013,8/6/2013,5/30/2013,,16,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,5/15/2013,8/6/2013,5/30/2013,,16,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,5/15/2013,8/6/2013,5/30/2013,,16,NA,NA,NA,,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,NA,APPLICATION SITE DISCHARGE,NA,HLT_0200,NA,HLGT_0457,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,5/15/2013,8/6/2013,5/31/2013,,17,5/31/2013,17,1,DAY,HIP FRACTURE,HIP FRACTURE,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,5/15/2013,8/6/2013,6/9/2013,,26,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,5/15/2013,8/6/2013,6/9/2013,,26,NA,NA,NA,,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,5/15/2013,8/6/2013,6/28/2013,,45,6/28/2013,45,1,DAY,SKIN LESION EXCISION,SKIN LESION EXCISION,NA,SKIN LESION EXCISION,NA,HLT_0498,NA,HLGT_0450,NA,SURGICAL AND MEDICAL PROCEDURES,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,1/26/2013,6/13/2013,2/5/2013,,11,2/13/2013,19,9,DAY,LOCALISED INFECTION,INFECTED FINGER,NA,LOCALISED INFECTION,NA,HLT_0435,NA,HLGT_0557,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,1/26/2013,6/13/2013,2/5/2013,,11,2/13/2013,19,9,DAY,LOCALISED INFECTION,INFECTED FINGER,NA,LOCALISED INFECTION,NA,HLT_0435,NA,HLGT_0557,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,1/26/2013,6/13/2013,3/14/2013,,48,NA,NA,NA,,BLOOD URINE PRESENT,BLOOD IN URINE,NA,BLOOD URINE PRESENT,NA,HLT_0458,NA,HLGT_0289,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,1/26/2013,6/13/2013,3/17/2013,,51,3/17/2013,51,1,DAY,CYSTOSCOPY,CYSTOSCOPY,NA,CYSTOSCOPY,NA,HLT_0436,NA,HLGT_0041,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,1/26/2013,6/13/2013,3/17/2013,,51,3/30/2013,64,14,DAY,BENIGN PROSTATIC HYPERPLASIA,ENLARGED PROSTATE,NA,BENIGN PROSTATIC HYPERPLASIA,NA,HLT_0215,NA,HLGT_0568,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MILD,N,N,N,N,N,Y,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,1/26/2013,6/13/2013,3/17/2013,,51,3/30/2013,64,14,DAY,BENIGN PROSTATIC HYPERPLASIA,ENLARGED PROSTATE,NA,BENIGN PROSTATIC HYPERPLASIA,NA,HLT_0215,NA,HLGT_0568,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,1/26/2013,6/13/2013,4/13/2013,,78,4/14/2013,79,2,DAY,PYREXIA,FEVER,NA,PYREXIA,NA,HLT_0310,NA,HLGT_0652,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,1/26/2013,6/13/2013,4/13/2013,,78,4/14/2013,79,2,DAY,DEHYDRATION,DEHYDRATION,NA,DEHYDRATION,NA,HLT_0533,NA,HLGT_0011,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,1/26/2013,6/13/2013,4/13/2013,,78,4/14/2013,79,2,DAY,HYPOTENSION,LOW BLOOD PRESSURE,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,1/26/2013,6/13/2013,4/20/2013,,85,6/13/2013,139,55,DAY,ORTHOSTATIC HYPOTENSION,POSTURAL HYPOTENSION,NA,ORTHOSTATIC HYPOTENSION,NA,HLT_0194,NA,HLGT_0111,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,1/26/2013,6/13/2013,4/20/2013,,85,6/13/2013,139,55,DAY,ORTHOSTATIC HYPOTENSION,POSTURAL HYPOTENSION,NA,ORTHOSTATIC HYPOTENSION,NA,HLT_0194,NA,HLGT_0111,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,11,Y,,,,,,,,
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,3/24/2013,5/23/2013,4/14/2013,,22,NA,NA,NA,,HEMIANOPIA HOMONYMOUS,HOMONYMOUS HEMIANOPSIA,NA,HEMIANOPIA HOMONYMOUS,NA,HLT_0639,NA,HLGT_0547,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,Y,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,3/24/2013,5/23/2013,4/19/2013,,27,5/31/2013,69,43,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,3/24/2013,5/23/2013,4/19/2013,,27,5/31/2013,69,43,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,3/24/2013,5/23/2013,5/19/2013,,57,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,3/24/2013,5/23/2013,4/19/2013,,27,5/31/2013,69,43,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,3/24/2013,5/23/2013,4/19/2013,,27,5/31/2013,69,43,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1301,Placebo,0,62,<65,1,WHITE,1,F,Y,7/19/2013,1/17/2014,8/30/2013,,43,NA,NA,NA,,DIABETES MELLITUS,DIABETES,NA,DIABETES MELLITUS,NA,HLT_0447,NA,HLGT_0572,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2/3/2014,6/16/2014,4/20/2014,,77,6/23/2014,141,65,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2/3/2014,6/16/2014,4/20/2014,,77,6/23/2014,141,65,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2/3/2014,6/16/2014,4/20/2014,,77,6/23/2014,141,65,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2/3/2014,6/16/2014,4/20/2014,,77,6/23/2014,141,65,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2/3/2014,6/16/2014,5/4/2014,,91,6/23/2014,141,51,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2/3/2014,6/16/2014,5/20/2014,,107,5/23/2014,110,4,DAY,DRUG ERUPTION,DRUG RASH,NA,DRUG ERUPTION,NA,HLT_0430,NA,HLGT_0253,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2/3/2014,6/16/2014,4/20/2014,,77,6/23/2014,141,65,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2/3/2014,6/16/2014,4/20/2014,,77,6/23/2014,141,65,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2/3/2014,6/16/2014,5/4/2014,,91,6/23/2014,141,51,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,9,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,6/10/2013,,-9,7/1/2013,13,22,DAY,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,NA,RASH MACULO-PAPULAR,NA,HLT_0500,NA,HLGT_0097,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,6/18/2013,,-1,7/16/2013,28,29,DAY,RASH PAPULAR,PAPULAR RASH,NA,RASH PAPULAR,NA,HLT_0549,NA,HLGT_0007,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,6/19/2013,,1,6/19/2013,1,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,6/19/2013,,1,6/19/2013,1,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,6/19/2013,,1,6/20/2013,2,2,DAY,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,6/19/2013,,1,6/20/2013,2,2,DAY,NIGHTMARE,NIGHTMARE,NA,NIGHTMARE,NA,HLT_0186,NA,HLGT_0049,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,6/20/2013,,2,NA,NA,NA,,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,NA,RASH MACULO-PAPULAR,NA,HLT_0500,NA,HLGT_0097,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,6/26/2013,,8,6/26/2013,8,1,DAY,BIOPSY,BIOPSY,NA,BIOPSY,NA,HLT_0685,NA,HLGT_0076,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,7/1/2013,,13,7/1/2013,13,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,6/10/2013,,-9,7/1/2013,13,22,DAY,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,NA,RASH MACULO-PAPULAR,NA,HLT_0500,NA,HLGT_0097,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,10,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,7/1/2013,,13,7/1/2013,13,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,11,Y,,,,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,7/4/2013,,16,7/4/2013,16,1,DAY,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOSIS,NA,ALLERGIC GRANULOMATOUS ANGIITIS,NA,HLT_0114,NA,HLGT_0157,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,12,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,6/18/2013,,-1,7/16/2013,28,29,DAY,RASH PAPULAR,PAPULAR RASH,NA,RASH PAPULAR,NA,HLT_0549,NA,HLGT_0007,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,13,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,7/28/2013,,40,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,14,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,6/19/2013,12/19/2013,9/6/2013,,80,NA,NA,NA,,FEELING COLD,FEELING COLD,NA,FEELING COLD,NA,HLT_0340,NA,HLGT_0717,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,15,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1312,Placebo,0,68,65-80,2,WHITE,1,F,Y,4/20/2014,10/19/2014,5/17/2014,,28,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1312,Placebo,0,68,65-80,2,WHITE,1,F,Y,4/20/2014,10/19/2014,10/19/2014,,183,NA,NA,NA,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,4/5/2013,10/2/2013,5/1/2013,,27,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,4/5/2013,10/2/2013,5/1/2013,,27,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,4/5/2013,10/2/2013,5/21/2013,,47,5/21/2013,47,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,4/5/2013,10/2/2013,5/21/2013,,47,5/21/2013,47,1,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,4/5/2013,10/2/2013,6/7/2013,,64,6/17/2013,74,11,DAY,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,NA,APPLICATION SITE BLEEDING,NA,HLT_0718,NA,HLGT_0324,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,4/5/2013,10/2/2013,7/12/2013,,99,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1329,Xanomeline High Dose,81,70,65-80,2,WHITE,1,M,Y,8/15/2013,8/25/2013,8/25/2013,,11,8/25/2013,11,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1329,Xanomeline High Dose,81,70,65-80,2,WHITE,1,M,Y,8/15/2013,8/25/2013,8/25/2013,,11,8/25/2013,11,1,DAY,PYREXIA,FEVER,NA,PYREXIA,NA,HLT_0310,NA,HLGT_0652,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1339,Placebo,0,81,>80,3,WHITE,1,M,Y,12/23/2012,6/24/2013,11/1/2011,D,-418,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,709,01-709-1339,Placebo,0,81,>80,3,WHITE,1,M,Y,12/23/2012,6/24/2013,5/12/2013,,141,NA,NA,NA,,BLOOD ALKALINE PHOSPHATASE INCREASED,ALK PHOS RAISED,NA,BLOOD ALKALINE PHOSPHATASE INCREASED,NA,HLT_0615,NA,HLGT_0298,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1424,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,3/3/2013,3/7/2013,3/7/2013,,5,3/7/2013,5,1,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,Y,N,N,N,N,N,Y,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,Y,Y,Y,,
CDISCPILOT01,710,01-710-1002,Xanomeline Low Dose,54,88,>80,3,WHITE,1,M,Y,1/14/2014,1/18/2014,1/16/2014,,3,1/20/2014,7,5,DAY,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,Y,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1002,Xanomeline Low Dose,54,88,>80,3,WHITE,1,M,Y,1/14/2014,1/18/2014,1/16/2014,,3,1/20/2014,7,5,DAY,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,Y,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2/10/2013,8/9/2013,2/18/2013,,9,2/19/2013,10,2,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2/10/2013,8/9/2013,3/1/2013,,20,NA,NA,NA,,SALIVARY HYPERSECRETION,SALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2/10/2013,8/9/2013,4/16/2013,,66,4/16/2013,66,1,DAY,DIZZINESS,FELT FAINT,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2/10/2013,8/9/2013,4/17/2013,,67,4/19/2013,69,3,DAY,URINARY TRACT INFECTION,URINARY INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2/10/2013,8/9/2013,4/17/2013,,67,4/17/2013,67,1,DAY,NEPHROLITHIASIS,KIDNEY STONE,NA,NEPHROLITHIASIS,NA,HLT_0439,NA,HLGT_0546,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2/10/2013,8/9/2013,5/18/2013,,98,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2/10/2013,8/9/2013,6/29/2013,,140,7/4/2013,145,6,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2/10/2013,8/9/2013,6/29/2013,,140,7/4/2013,145,6,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2/10/2013,8/9/2013,8/8/2013,,180,8/8/2013,180,1,DAY,FALL,FALL,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,10,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2/10/2013,8/9/2013,8/8/2013,,180,NA,NA,NA,,FACIAL BONES FRACTURE,FRACTURED NOSE,NA,FACIAL BONES FRACTURE,NA,HLT_0305,NA,HLGT_0585,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2/10/2013,8/9/2013,8/8/2013,,180,NA,NA,NA,,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,12,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1021,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,9/27/2013,10/29/2013,10/10/2013,,14,10/10/2013,14,1,DAY,CHEST PAIN,CHEST PAIN,NA,CHEST PAIN,NA,HLT_0717,NA,HLGT_0195,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1021,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,9/27/2013,10/29/2013,10/21/2013,,25,10/31/2013,35,11,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1021,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,9/27/2013,10/29/2013,10/21/2013,,25,10/31/2013,35,11,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1027,Placebo,0,83,>80,3,WHITE,1,M,Y,2/28/2014,8/29/2014,5/9/2014,,71,6/1/2014,94,24,DAY,HAEMOPTYSIS,COUGHING BLOOD,NA,HAEMOPTYSIS,NA,HLT_0192,NA,HLGT_0680,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1027,Placebo,0,83,>80,3,WHITE,1,M,Y,2/28/2014,8/29/2014,5/23/2014,,85,6/20/2014,113,29,DAY,RALES,RALES,NA,RALES,NA,HLT_0020,NA,HLGT_0410,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1027,Placebo,0,83,>80,3,WHITE,1,M,Y,2/28/2014,8/29/2014,5/9/2014,,71,6/1/2014,94,24,DAY,HAEMOPTYSIS,COUGHING BLOOD,NA,HAEMOPTYSIS,NA,HLT_0192,NA,HLGT_0680,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,710,01-710-1027,Placebo,0,83,>80,3,WHITE,1,M,Y,2/28/2014,8/29/2014,5/23/2014,,85,6/20/2014,113,29,DAY,RALES,RALES,NA,RALES,NA,HLT_0020,NA,HLGT_0410,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,6/3/2013,8/13/2013,6/22/2013,,20,6/22/2013,20,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,6/3/2013,8/13/2013,7/2/2013,,30,7/9/2013,37,8,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,6/3/2013,8/13/2013,7/2/2013,,30,8/17/2013,76,47,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,6/3/2013,8/13/2013,7/2/2013,,30,7/9/2013,37,8,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,6/3/2013,8/13/2013,7/22/2013,,50,8/17/2013,76,27,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,6/3/2013,8/13/2013,8/3/2013,,62,8/17/2013,76,15,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,6/3/2013,8/13/2013,8/13/2013,,72,8/17/2013,76,5,DAY,SKIN EXFOLIATION,SKIN PEELING,NA,SKIN EXFOLIATION,NA,HLT_0236,NA,HLGT_0726,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,6/3/2013,8/13/2013,7/2/2013,,30,8/17/2013,76,47,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,10,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,6/3/2013,8/13/2013,7/22/2013,,50,8/17/2013,76,27,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,6/3/2013,8/13/2013,8/3/2013,,62,8/17/2013,76,15,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,12,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,6/3/2013,8/13/2013,8/13/2013,,72,8/17/2013,76,5,DAY,SKIN EXFOLIATION,SKIN PEELING,NA,SKIN EXFOLIATION,NA,HLT_0236,NA,HLGT_0726,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,13,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1053,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,12/26/2012,2/10/2013,1/28/2013,,34,2/11/2013,48,15,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1053,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,12/26/2012,2/10/2013,1/28/2013,,34,2/11/2013,48,15,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1053,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,12/26/2012,2/10/2013,1/28/2013,,34,2/11/2013,48,15,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1053,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,12/26/2012,2/10/2013,1/28/2013,,34,2/11/2013,48,15,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,1/1/2013,7/5/2013,1/2/2013,,2,1/2/2013,2,1,DAY,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,1/1/2013,7/5/2013,1/4/2013,,4,1/15/2013,15,12,DAY,INSOMNIA,DIFFICULTY SLEEPING,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,1/1/2013,7/5/2013,1/4/2013,,4,1/15/2013,15,12,DAY,INSOMNIA,DIFFICULTY SLEEPING,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,1/1/2013,7/5/2013,1/21/2013,,21,1/21/2013,21,1,DAY,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,NA,APPLICATION SITE INDURATION,NA,HLT_0696,NA,HLGT_0715,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,1/1/2013,7/5/2013,1/23/2013,,23,1/23/2013,23,1,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,1/1/2013,7/5/2013,1/31/2013,,31,1/31/2013,31,1,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,1/1/2013,7/5/2013,2/8/2013,,39,2/8/2013,39,1,DAY,FALL,FALLING DOWN,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,1/1/2013,7/5/2013,2/9/2013,,40,2/9/2013,40,1,DAY,FALL,FALLING DOWN,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,9/8/2012,1/22/2013,10/6/2012,,29,NA,NA,NA,,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,9/8/2012,1/22/2013,12/12/2012,,96,NA,NA,NA,,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,9/8/2012,1/22/2013,12/12/2012,,96,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,9/8/2012,1/22/2013,12/12/2012,,96,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,9/8/2012,1/22/2013,1/22/2013,,137,1/25/2013,140,4,DAY,HIP FRACTURE,HIP FRACTURE,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,9/8/2012,1/22/2013,2/5/2013,,151,2/10/2013,156,6,DAY,GASTROINTESTINAL HAEMORRHAGE,GI BLEED,NA,GASTROINTESTINAL HAEMORRHAGE,NA,HLT_0354,NA,HLGT_0020,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1077,Placebo,0,76,65-80,2,WHITE,1,F,Y,11/17/2013,5/18/2014,12/12/2013,,26,12/12/2013,26,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1077,Placebo,0,76,65-80,2,WHITE,1,F,Y,11/17/2013,5/18/2014,1/12/2014,,57,NA,NA,NA,,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1137,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,10/11/2013,11/13/2013,10/13/2013,,3,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1137,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,10/11/2013,11/13/2013,10/13/2013,,3,NA,NA,NA,,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1137,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,10/11/2013,11/13/2013,11/4/2013,,25,NA,NA,NA,,VERTIGO,VERTIGO,NA,VERTIGO,NA,HLT_0255,NA,HLGT_0147,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1137,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,10/11/2013,11/13/2013,11/13/2013,,34,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1142,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,10/2/2012,10/20/2012,10/4/2012,,3,10/6/2012,5,3,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1142,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,10/2/2012,10/20/2012,10/4/2012,,3,10/6/2012,5,3,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1142,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,10/2/2012,10/20/2012,10/14/2012,,13,10/14/2012,13,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1142,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,10/2/2012,10/20/2012,10/19/2012,,18,10/19/2012,18,1,DAY,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NA,SYNCOPE VASOVAGAL,NA,HLT_0003,NA,HLGT_0687,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1166,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,11/30/2012,3/19/2013,3/19/2013,,110,3/19/2013,110,1,DAY,FALL,FALL,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1166,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,11/30/2012,3/19/2013,3/19/2013,,110,3/19/2013,110,1,DAY,SKIN LACERATION,LACERATION OF HEAD,NA,SKIN LACERATION,NA,HLT_0075,NA,HLGT_0118,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1166,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,11/30/2012,3/19/2013,3/19/2013,,110,3/19/2013,110,1,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1166,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,11/30/2012,3/19/2013,3/19/2013,,110,3/20/2013,111,2,DAY,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NA,COMPLEX PARTIAL SEIZURES,NA,HLT_0558,NA,HLGT_0656,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1166,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,11/30/2012,3/19/2013,3/20/2013,,111,3/20/2013,111,1,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,710,01-710-1183,Placebo,0,80,65-80,2,WHITE,1,F,Y,11/16/2013,5/17/2014,3/10/2014,,115,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1183,Placebo,0,80,65-80,2,WHITE,1,F,Y,11/16/2013,5/17/2014,3/10/2014,,115,NA,NA,NA,,ATRIOVENTRICULAR BLOCK FIRST DEGREE,FIRST DEGREE ATRIOVENTRICULAR BLOCK,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,NA,HLT_0419,NA,HLGT_0464,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1187,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,11/10/2012,5/12/2013,12/23/2012,,44,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1235,Xanomeline Low Dose,54,56,<65,1,WHITE,1,F,Y,9/26/2012,3/27/2013,11/22/2012,,58,12/14/2012,80,23,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1235,Xanomeline Low Dose,54,56,<65,1,WHITE,1,F,Y,9/26/2012,3/27/2013,1/29/2013,,126,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1249,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,12/28/2013,6/28/2014,2/11/2014,,46,2/11/2014,46,1,DAY,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1249,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,12/28/2013,6/28/2014,2/18/2014,,53,2/18/2014,53,1,DAY,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1249,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,12/28/2013,6/28/2014,2/23/2014,,58,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1249,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,12/28/2013,6/28/2014,4/24/2014,,118,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,6/13/2013,10/11/2013,7/3/2013,,21,7/5/2013,23,3,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,6/13/2013,10/11/2013,8/21/2013,,70,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,6/13/2013,10/11/2013,8/21/2013,,70,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,6/13/2013,10/11/2013,9/29/2013,,109,9/29/2013,109,1,DAY,COLD SWEAT,COLD SWEAT,NA,COLD SWEAT,NA,HLT_0124,NA,HLGT_0208,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,6/13/2013,10/11/2013,9/29/2013,,109,9/29/2013,109,1,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,6/13/2013,10/11/2013,10/9/2013,,119,10/9/2013,119,1,DAY,COLD SWEAT,COLD SWEAT,NA,COLD SWEAT,NA,HLT_0124,NA,HLGT_0208,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,6/13/2013,10/11/2013,10/9/2013,,119,10/9/2013,119,1,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,6/13/2013,10/11/2013,10/11/2013,,121,10/11/2013,121,1,DAY,COLD SWEAT,COLD SWEAT,NA,COLD SWEAT,NA,HLT_0124,NA,HLGT_0208,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,6/13/2013,10/11/2013,10/11/2013,,121,10/11/2013,121,1,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,710,01-710-1270,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2/12/2014,3/1/2014,2/23/2014,,12,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1270,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2/12/2014,3/1/2014,2/23/2014,,12,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1271,Placebo,0,86,>80,3,WHITE,1,F,Y,9/27/2012,11/21/2012,11/21/2012,,56,11/21/2012,56,1,DAY,DYSPNOEA,SHORTNESS OF BREATH,NA,DYSPNOEA,NA,HLT_0296,NA,HLGT_0255,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1271,Placebo,0,86,>80,3,WHITE,1,F,Y,9/27/2012,11/21/2012,11/21/2012,,56,11/26/2012,61,6,DAY,ATRIAL FIBRILLATION,PAROXYSMAL ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,Y,Y,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1271,Placebo,0,86,>80,3,WHITE,1,F,Y,9/27/2012,11/21/2012,11/22/2012,,57,NA,NA,NA,,CARDIAC FAILURE CONGESTIVE,CONGESTIVE HEART FAILURE,NA,CARDIAC FAILURE CONGESTIVE,NA,HLT_0511,NA,HLGT_0413,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,Y,Y,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1271,Placebo,0,86,>80,3,WHITE,1,F,Y,9/27/2012,11/21/2012,11/22/2012,,57,11/26/2012,61,5,DAY,HYPONATRAEMIA,HYPONATREMIA,NA,HYPONATRAEMIA,NA,HLT_0688,NA,HLGT_0102,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,N,N,N,N,Y,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,12/24/2012,2/26/2013,1/13/2013,,21,1/19/2013,27,7,DAY,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,12/24/2012,2/26/2013,2/7/2013,,46,3/3/2013,70,25,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,12/24/2012,2/26/2013,2/24/2013,,63,3/3/2013,70,8,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,12/24/2012,2/26/2013,2/24/2013,,63,2/26/2013,65,3,DAY,BURNING SENSATION,BURNING SENSATION,NA,BURNING SENSATION,NA,HLT_0775,NA,HLGT_0456,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,12/24/2012,2/26/2013,3/2/2013,,69,3/2/2013,69,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,12/24/2012,2/26/2013,2/7/2013,,46,3/3/2013,70,25,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,12/24/2012,2/26/2013,2/24/2013,,63,3/3/2013,70,8,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1300,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,12/15/2012,2/15/2013,1/31/2013,,48,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1300,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,12/15/2012,2/15/2013,2/10/2013,,58,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1300,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,12/15/2012,2/15/2013,2/10/2013,,58,NA,NA,NA,,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1300,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,12/15/2012,2/15/2013,2/13/2013,,61,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1314,Placebo,0,78,65-80,2,WHITE,1,F,Y,4/24/2013,5/23/2013,5/20/2013,,27,5/24/2013,31,5,DAY,NASOPHARYNGITIS,COMMON COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1314,Placebo,0,78,65-80,2,WHITE,1,F,Y,4/24/2013,5/23/2013,5/20/2013,,27,5/24/2013,31,5,DAY,NASOPHARYNGITIS,COMMON COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2/27/2013,7/6/2013,2/26/2013,,-1,2/26/2013,-1,1,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,N,,,,,,,,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2/27/2013,7/6/2013,5/14/2013,,77,7/7/2013,131,55,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2/27/2013,7/6/2013,6/18/2013,,112,7/7/2013,131,20,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2/27/2013,7/6/2013,6/18/2013,,112,7/7/2013,131,20,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2/27/2013,7/6/2013,5/14/2013,,77,7/7/2013,131,55,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2/27/2013,7/6/2013,6/18/2013,,112,7/7/2013,131,20,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2/27/2013,7/6/2013,6/18/2013,,112,7/7/2013,131,20,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1354,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,11/11/2012,5/1/2013,12/30/2012,,50,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1354,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,11/11/2012,5/1/2013,2/14/2013,,96,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1358,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,9/17/2012,2/9/2013,12/22/2012,,97,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1358,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,9/17/2012,2/9/2013,12/22/2012,,97,NA,NA,NA,,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1358,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,9/17/2012,2/9/2013,1/24/2013,,130,NA,NA,NA,,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,NA,APPLICATION SITE DESQUAMATION,NA,HLT_0351,NA,HLGT_0193,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1368,Placebo,0,88,>80,3,WHITE,1,F,Y,10/23/2013,4/24/2014,12/25/2013,,64,4/24/2014,184,121,DAY,HIP FRACTURE,FRACTURED HIP,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1368,Placebo,0,88,>80,3,WHITE,1,F,Y,10/23/2013,4/24/2014,3/26/2014,,155,NA,NA,NA,,DELUSION,DELUSIONS,NA,DELUSION,NA,HLT_0198,NA,HLGT_0565,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1368,Placebo,0,88,>80,3,WHITE,1,F,Y,10/23/2013,4/24/2014,3/26/2014,,155,NA,NA,NA,,PSYCHOMOTOR HYPERACTIVITY,INCREASED ACTIVITY,NA,PSYCHOMOTOR HYPERACTIVITY,NA,HLT_0383,NA,HLGT_0277,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1368,Placebo,0,88,>80,3,WHITE,1,F,Y,10/23/2013,4/24/2014,12/25/2013,,64,4/24/2014,184,121,DAY,HIP FRACTURE,FRACTURED HIP,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,10/29/2012,2/18/2013,11/26/2012,,29,NA,NA,NA,,ATRIOVENTRICULAR BLOCK FIRST DEGREE,FIRST DEGREE ATRIOVENTRICULAR BLOCK,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,NA,HLT_0419,NA,HLGT_0464,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,10/29/2012,2/18/2013,12/18/2012,,51,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,10/29/2012,2/18/2013,12/27/2012,,60,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,10/29/2012,2/18/2013,12/27/2012,,60,NA,NA,NA,,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,10/29/2012,2/18/2013,2/18/2013,,113,NA,NA,NA,,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,10/29/2012,2/18/2013,2/18/2013,,113,NA,NA,NA,,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,T WAVE FLATTENING OF,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,NA,HLT_0037,NA,HLGT_0030,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1408,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,1/5/2013,7/12/2013,1/31/2013,,27,2/9/2013,36,10,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1408,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,1/5/2013,7/12/2013,1/31/2013,,27,2/9/2013,36,10,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,710,01-710-1408,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,1/5/2013,7/12/2013,2/24/2013,,51,5/31/2013,147,97,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1408,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,1/5/2013,7/12/2013,2/24/2013,,51,5/31/2013,147,97,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,4/3/2013,4/29/2013,4/16/2013,,14,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,4/3/2013,4/29/2013,4/16/2013,,14,5/2/2013,30,17,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,4/3/2013,4/29/2013,4/16/2013,,14,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,4/3/2013,4/29/2013,4/16/2013,,14,5/2/2013,30,17,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,4/3/2013,4/29/2013,4/27/2013,,25,NA,NA,NA,,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,4/3/2013,4/29/2013,4/29/2013,,27,5/1/2013,29,3,DAY,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,NA,APPLICATION SITE URTICARIA,NA,HLT_0196,NA,HLGT_0233,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,4/3/2013,4/29/2013,4/16/2013,,14,5/2/2013,30,17,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1036,Placebo,0,70,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,7/29/2012,2/10/2013,7/29/2012,,1,NA,NA,NA,,HEADACHE,INTERMITTENT HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,711,01-711-1036,Placebo,0,70,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,7/29/2012,2/10/2013,8/4/2012,,7,8/12/2012,15,9,DAY,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1036,Placebo,0,70,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,7/29/2012,2/10/2013,8/12/2012,,15,NA,NA,NA,,GLOSSITIS,GLOSSITIS,NA,GLOSSITIS,NA,HLT_0250,NA,HLGT_0427,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1036,Placebo,0,70,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,7/29/2012,2/10/2013,8/4/2012,,7,8/12/2012,15,9,DAY,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,10/1/2007,D,-2011,NA,NA,NA,,TINNITUS,TINNITUS,NA,TINNITUS,NA,HLT_0570,NA,HLGT_0180,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,4/11/2013,,9,NA,NA,NA,,PARAESTHESIA ORAL,TINGLING MOUTH,NA,PARAESTHESIA ORAL,NA,HLT_0727,NA,HLGT_0035,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,4/28/2013,,26,5/11/2013,39,14,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,SEVERE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,4/29/2013,,27,5/15/2013,43,17,DAY,SUPRAVENTRICULAR EXTRASYSTOLES,ECTOPIC ATRIAL BEATS,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,4/28/2013,,26,5/11/2013,39,14,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,4/28/2013,,26,5/11/2013,39,14,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,4/29/2013,,27,5/15/2013,43,17,DAY,SUPRAVENTRICULAR EXTRASYSTOLES,ECTOPIC ATRIAL BEATS,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,5/18/2013,,46,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,5/27/2013,,55,5/31/2013,59,5,DAY,RASH PRURITIC,ITCHY RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,5/28/2013,,56,6/1/2013,60,5,DAY,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRACTIONS,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,5/27/2013,,55,5/31/2013,59,5,DAY,RASH PRURITIC,ITCHY RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,5/30/2013,,58,NA,NA,NA,,CONJUNCTIVAL HAEMORRHAGE,SUBCONJUNCTIVAL HEMORRHAGE,NA,CONJUNCTIVAL HAEMORRHAGE,NA,HLT_0013,NA,HLGT_0720,NA,EYE DISORDERS,EYE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,12,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,6/1/2013,,60,NA,NA,NA,,CERUMEN IMPACTION,CERUMEN IMPACTION,NA,CERUMEN IMPACTION,NA,HLT_0018,NA,HLGT_0158,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,13,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/3/2013,5/30/2013,5/28/2013,,56,6/1/2013,60,5,DAY,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRACTIONS,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,14,Y,,,,,,,,
CDISCPILOT01,711,01-711-1433,Xanomeline High Dose,81,84,>80,3,WHITE,1,F,Y,1/27/2013,2/5/2013,7/23/2012,,-188,NA,NA,NA,,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,711,01-711-1433,Xanomeline High Dose,81,84,>80,3,WHITE,1,F,Y,1/27/2013,2/5/2013,7/23/2012,,-188,NA,NA,NA,,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,N,,,,,,,,
CDISCPILOT01,711,01-711-1433,Xanomeline High Dose,81,84,>80,3,WHITE,1,F,Y,1/27/2013,2/5/2013,2/5/2013,,10,NA,NA,NA,,ASTHENIA,WEAKNESS,NA,ASTHENIA,NA,HLT_0205,NA,HLGT_0614,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,Y,Y,Y,,,,,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,9/15/2013,3/24/2014,9/26/2013,,12,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,9/15/2013,3/24/2014,10/11/2013,,27,10/11/2013,27,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,9/15/2013,3/24/2014,10/11/2013,,27,10/11/2013,27,1,DAY,VOMITING,EMESIS,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,9/15/2013,3/24/2014,9/26/2013,,12,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,9/15/2013,3/24/2014,10/11/2013,,27,10/11/2013,27,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,9/15/2013,3/24/2014,10/11/2013,,27,10/11/2013,27,1,DAY,VOMITING,EMESIS,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,9/15/2013,3/24/2014,3/8/2014,,175,3/8/2014,175,1,DAY,CATARACT OPERATION,CATARACT EXTRACTION,NA,CATARACT OPERATION,NA,HLT_0432,NA,HLGT_0058,NA,SURGICAL AND MEDICAL PROCEDURES,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1073,Xanomeline Low Dose,54,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,3/30/2014,10/5/2014,7/14/2014,,107,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1141,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,5/31/2013,7/1/2013,6/21/2013,,22,7/15/2013,46,25,DAY,RASH PRURITIC,PRURITIC RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1141,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,5/31/2013,7/1/2013,6/21/2013,,22,7/15/2013,46,25,DAY,RASH PRURITIC,PRURITIC RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1141,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,5/31/2013,7/1/2013,6/30/2013,,31,NA,NA,NA,,BACK PAIN,BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1141,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,5/31/2013,7/1/2013,7/1/2013,,32,7/15/2013,46,15,DAY,DELIRIUM,DELIRIUM,NA,DELIRIUM,NA,HLT_0376,NA,HLGT_0176,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,8/19/2013,,11,8/23/2013,15,5,DAY,DYSURIA,MICTURITION BURNING,NA,DYSURIA,NA,HLT_0637,NA,HLGT_0210,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,8/22/2013,,14,8/22/2013,14,1,DAY,DYSPEPSIA,HEARTBURN,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,8/28/2013,,20,9/8/2013,31,12,DAY,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,9/5/2013,,28,NA,NA,NA,,ASTHENIA,LOWER EXTREMITIES WEAKNESS OF,NA,ASTHENIA,NA,HLT_0205,NA,HLGT_0614,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,8/28/2013,,20,9/8/2013,31,12,DAY,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,9/5/2013,,28,NA,NA,NA,,ASTHENIA,LOWER EXTREMITIES WEAKNESS OF,NA,ASTHENIA,NA,HLT_0205,NA,HLGT_0614,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,9/12/2013,,35,NA,NA,NA,,DYSPEPSIA,INDIGESTION,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,10/10/2013,,63,1/18/2014,163,101,DAY,PELVIC PAIN,PELVIC PAIN,NA,PELVIC PAIN,NA,HLT_0189,NA,HLGT_0691,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,10/10/2013,,63,10/13/2013,66,4,DAY,GASTROENTERITIS VIRAL,STOMACH FLU,NA,GASTROENTERITIS VIRAL,NA,HLT_0211,NA,HLGT_0385,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,Y,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,10/10/2013,,63,NA,NA,NA,,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,NA,GASTROOESOPHAGEAL REFLUX DISEASE,NA,HLT_0407,NA,HLGT_0304,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,11/23/2013,,107,12/2/2013,116,10,DAY,VAGINAL MYCOSIS,VAGINAL YEAST INFECTION,NA,VAGINAL MYCOSIS,NA,HLT_0508,NA,HLGT_0643,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,11/23/2013,,107,12/2/2013,116,10,DAY,CERVICITIS,CERVICITIS,NA,CERVICITIS,NA,HLT_0651,NA,HLGT_0282,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,12,Y,,,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,11/23/2013,,107,12/2/2013,116,10,DAY,VAGINAL MYCOSIS,VAGINAL YEAST INFECTION,NA,VAGINAL MYCOSIS,NA,HLT_0508,NA,HLGT_0643,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,13,Y,,,,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,11/23/2013,,107,12/2/2013,116,10,DAY,CERVICITIS,CERVICITIS,NA,CERVICITIS,NA,HLT_0651,NA,HLGT_0282,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,14,Y,,,,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,8/9/2013,2/5/2014,10/10/2013,,63,1/18/2014,163,101,DAY,PELVIC PAIN,PELVIC PAIN,NA,PELVIC PAIN,NA,HLT_0189,NA,HLGT_0691,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,15,Y,,,,,,,,
CDISCPILOT01,713,01-713-1209,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,5/27/2013,11/22/2013,5/30/2013,,4,NA,NA,NA,,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,713,01-713-1209,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,5/27/2013,11/22/2013,6/2/2013,,7,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1209,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,5/27/2013,11/22/2013,5/30/2013,,4,NA,NA,NA,,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,713,01-713-1209,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,5/27/2013,11/22/2013,10/31/2013,,158,NA,NA,NA,,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1256,Placebo,0,71,65-80,2,WHITE,1,M,Y,9/19/2012,3/25/2013,10/30/2012,,42,10/31/2012,43,2,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1256,Placebo,0,71,65-80,2,WHITE,1,M,Y,9/19/2012,3/25/2013,10/30/2012,,42,10/31/2012,43,2,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1269,Placebo,0,73,65-80,2,WHITE,1,M,Y,1/27/2014,7/28/2014,2/2/2014,,7,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1269,Placebo,0,73,65-80,2,WHITE,1,M,Y,1/27/2014,7/28/2014,4/18/2014,,82,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1269,Placebo,0,73,65-80,2,WHITE,1,M,Y,1/27/2014,7/28/2014,7/10/2014,,165,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1269,Placebo,0,73,65-80,2,WHITE,1,M,Y,1/27/2014,7/28/2014,7/10/2014,,165,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1448,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,1/19/2014,5/16/2014,3/19/2014,,60,5/23/2014,125,66,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1448,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,1/19/2014,5/16/2014,3/27/2014,,68,5/23/2014,125,58,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1448,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,1/19/2014,5/16/2014,3/19/2014,,60,5/23/2014,125,66,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1448,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,1/19/2014,5/16/2014,3/27/2014,,68,5/23/2014,125,58,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,4/17/2014,10/16/2014,5/26/2014,,40,6/4/2014,49,10,DAY,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANCH BLOCK,NA,BUNDLE BRANCH BLOCK RIGHT,NA,HLT_0751,NA,HLGT_0597,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,4/17/2014,10/16/2014,5/26/2014,,40,NA,NA,NA,,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERSION,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,4/17/2014,10/16/2014,6/4/2014,,49,6/17/2014,62,14,DAY,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,4/17/2014,10/16/2014,6/4/2014,,49,NA,NA,NA,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,4/17/2014,10/16/2014,5/26/2014,,40,6/4/2014,49,10,DAY,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANCH BLOCK,NA,BUNDLE BRANCH BLOCK RIGHT,NA,HLT_0751,NA,HLGT_0597,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,4/17/2014,10/16/2014,6/4/2014,,49,6/17/2014,62,14,DAY,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,4/17/2014,10/16/2014,7/18/2014,,93,7/24/2014,99,7,DAY,BRONCHITIS,BRONCHITIS,NA,BRONCHITIS,NA,HLT_0634,NA,HLGT_0523,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1068,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,8/8/2013,10/8/2013,9/20/2013,,44,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1068,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,8/8/2013,10/8/2013,9/20/2013,,44,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1068,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,8/8/2013,10/8/2013,9/20/2013,,44,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1068,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,8/8/2013,10/8/2013,9/20/2013,,44,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,4/26/2013,10/23/2013,5/12/2013,,17,7/17/2013,83,67,DAY,DIARRHOEA,LOOSE STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,4/26/2013,10/23/2013,5/12/2013,,17,7/17/2013,83,67,DAY,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,4/26/2013,10/23/2013,5/13/2013,,18,7/17/2013,83,66,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,4/26/2013,10/23/2013,5/14/2013,,19,NA,NA,NA,,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,4/26/2013,10/23/2013,5/17/2013,,22,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,4/26/2013,10/23/2013,5/12/2013,,17,7/17/2013,83,67,DAY,DIARRHOEA,LOOSE STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,4/26/2013,10/23/2013,5/12/2013,,17,7/17/2013,83,67,DAY,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,4/26/2013,10/23/2013,5/13/2013,,18,7/17/2013,83,66,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,4/26/2013,10/23/2013,7/25/2013,,91,8/6/2013,103,13,DAY,DYSURIA,URINATION DIFFICULTY,NA,DYSURIA,NA,HLT_0637,NA,HLGT_0210,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,12/4/2013,6/17/2014,12/13/2013,,10,12/13/2013,10,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,12/4/2013,6/17/2014,12/14/2013,,11,12/15/2013,12,2,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,12/4/2013,6/17/2014,1/11/2014,,39,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,12/4/2013,6/17/2014,1/22/2014,,50,1/25/2014,53,4,DAY,NASOPHARYNGITIS,HEAD COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,12/4/2013,6/17/2014,1/22/2014,,50,1/25/2014,53,4,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,12/4/2013,6/17/2014,2/24/2014,,83,4/8/2014,126,44,DAY,BACK PAIN,LOW BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,12/4/2013,6/17/2014,2/24/2014,,83,4/8/2014,126,44,DAY,BACK PAIN,LOW BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,12/4/2013,6/17/2014,5/27/2014,,175,NA,NA,NA,,SINUS BRADYCARDIA,BRADYCARDIA SINUS,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2/26/2013,9/7/2013,4/4/2013,,38,4/15/2013,49,12,DAY,EAR PAIN,EAR PAIN,NA,EAR PAIN,NA,HLT_0631,NA,HLGT_0432,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2/26/2013,9/7/2013,4/4/2013,,38,4/15/2013,49,12,DAY,EAR PAIN,EAR PAIN,NA,EAR PAIN,NA,HLT_0631,NA,HLGT_0432,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2/26/2013,9/7/2013,5/29/2013,,93,NA,NA,NA,,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2/26/2013,9/7/2013,6/16/2013,,111,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2/26/2013,9/7/2013,5/29/2013,,93,NA,NA,NA,,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2/26/2013,9/7/2013,6/16/2013,,111,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1425,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,8/15/2013,8/19/2013,8/13/2013,,-2,NA,NA,NA,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,715,01-715-1107,Xanomeline Low Dose,54,65,65-80,2,WHITE,1,M,Y,2/26/2013,5/7/2013,5/7/2013,,71,5/21/2013,85,15,DAY,DERMATITIS CONTACT,CONTACT DERMATITIS,NA,DERMATITIS CONTACT,NA,HLT_0056,NA,HLGT_0331,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,715,01-715-1107,Xanomeline Low Dose,54,65,65-80,2,WHITE,1,M,Y,2/26/2013,5/7/2013,5/13/2013,,77,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,715,01-715-1107,Xanomeline Low Dose,54,65,65-80,2,WHITE,1,M,Y,2/26/2013,5/7/2013,5/7/2013,,71,5/21/2013,85,15,DAY,DERMATITIS CONTACT,CONTACT DERMATITIS,NA,DERMATITIS CONTACT,NA,HLT_0056,NA,HLGT_0331,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,715,01-715-1207,Placebo,0,78,65-80,2,WHITE,1,F,Y,11/18/2012,5/27/2013,1/10/2013,,54,1/10/2013,54,1,DAY,NEPHROLITHIASIS,KIDNEY STONES,NA,NEPHROLITHIASIS,NA,HLT_0439,NA,HLGT_0546,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,715,01-715-1319,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2/17/2013,3/5/2013,3/18/2013,,30,3/18/2013,30,1,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,715,01-715-1321,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2/11/2014,4/21/2014,3/14/2014,,32,3/14/2014,32,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,715,01-715-1321,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2/11/2014,4/21/2014,3/14/2014,,32,3/14/2014,32,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,715,01-715-1321,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2/11/2014,4/21/2014,4/21/2014,,70,NA,NA,NA,,APPLICATION SITE REACTION,APPLICATION SITE REACTION,NA,APPLICATION SITE REACTION,NA,HLT_0339,NA,HLGT_0668,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,715,01-715-1321,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2/11/2014,4/21/2014,4/22/2014,,71,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,7/6/2013,7/7/2013,7/8/2013,,3,7/8/2013,3,1,DAY,PALPITATIONS,PALPITATIONS,NA,PALPITATIONS,NA,HLT_0493,NA,HLGT_0593,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,7/6/2013,7/7/2013,7/8/2013,,3,7/8/2013,3,1,DAY,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,7/6/2013,7/7/2013,7/8/2013,,3,7/8/2013,3,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,7/6/2013,7/7/2013,7/8/2013,,3,7/8/2013,3,1,DAY,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,7/6/2013,7/7/2013,7/13/2013,,8,7/13/2013,8,1,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,7/6/2013,7/7/2013,7/13/2013,,8,7/13/2013,8,1,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,716,01-716-1024,Placebo,0,87,>80,3,WHITE,1,F,Y,7/9/2012,1/20/2013,8/20/2012,,43,9/27/2012,81,39,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1024,Placebo,0,87,>80,3,WHITE,1,F,Y,7/9/2012,1/20/2013,8/20/2012,,43,9/27/2012,81,39,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,716,01-716-1024,Placebo,0,87,>80,3,WHITE,1,F,Y,7/9/2012,1/20/2013,12/16/2012,,161,NA,NA,NA,,EMPHYSEMA,EMPHYSEMA,NA,EMPHYSEMA,NA,HLT_0698,NA,HLGT_0221,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,4/2/2014,10/16/2014,4/17/2014,,16,NA,NA,NA,,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,4/2/2014,10/16/2014,4/17/2014,,16,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,4/2/2014,10/16/2014,4/18/2014,,17,7/31/2014,121,105,DAY,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,4/2/2014,10/16/2014,7/16/2014,,106,7/25/2014,115,10,DAY,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,4/2/2014,10/16/2014,7/31/2014,,121,NA,NA,NA,,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,T WAVE FLATTENING OF,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,NA,HLT_0037,NA,HLGT_0030,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,4/2/2014,10/16/2014,4/18/2014,,17,7/31/2014,121,105,DAY,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,4/2/2014,10/16/2014,8/15/2014,,136,8/27/2014,148,13,DAY,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,716,01-716-1044,Placebo,0,74,65-80,2,WHITE,1,M,Y,4/27/2013,11/3/2013,5/21/2013,,25,5/26/2013,30,6,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1044,Placebo,0,74,65-80,2,WHITE,1,M,Y,4/27/2013,11/3/2013,5/21/2013,,25,5/26/2013,30,6,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,716,01-716-1044,Placebo,0,74,65-80,2,WHITE,1,M,Y,4/27/2013,11/3/2013,10/15/2013,,172,NA,NA,NA,,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,5/9/2013,8/25/2013,5/9/2013,,1,NA,NA,NA,,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,5/9/2013,8/25/2013,7/1/2013,,54,NA,NA,NA,,FATIGUE,TIREDNESS,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,5/9/2013,8/25/2013,7/4/2013,,57,7/28/2013,81,25,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,5/9/2013,8/25/2013,7/4/2013,,57,7/28/2013,81,25,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,5/9/2013,8/25/2013,7/28/2013,,81,7/31/2013,84,4,DAY,RESTLESSNESS,RESTLESSNESS,NA,RESTLESSNESS,NA,HLT_0427,NA,HLGT_0510,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,5/9/2013,8/25/2013,7/31/2013,,84,NA,NA,NA,,LETHARGY,LETHARGY,NA,LETHARGY,NA,HLT_0027,NA,HLGT_0448,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,5/9/2013,8/25/2013,7/28/2013,,81,7/31/2013,84,4,DAY,RESTLESSNESS,RESTLESSNESS,NA,RESTLESSNESS,NA,HLT_0427,NA,HLGT_0510,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,716,01-716-1071,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,6/8/2013,8/1/2013,7/13/2013,,36,NA,NA,NA,,HYPERSOMNIA,SLEEP EXCESSIVE,NA,HYPERSOMNIA,NA,HLT_0231,NA,HLGT_0628,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1071,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,6/8/2013,8/1/2013,7/13/2013,,36,NA,NA,NA,,FATIGUE,TIREDNESS,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1071,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,6/8/2013,8/1/2013,7/31/2013,,54,7/31/2013,54,1,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,716,01-716-1094,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,12/19/2012,1/24/2013,1/19/2013,,32,NA,NA,NA,,ATRIAL FLUTTER,ATRIAL FLUTTER,NA,ATRIAL FLUTTER,NA,HLT_0477,NA,HLGT_0627,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1094,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,12/19/2012,1/24/2013,1/19/2013,,32,NA,NA,NA,,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANCH BLOCK,NA,BUNDLE BRANCH BLOCK RIGHT,NA,HLT_0751,NA,HLGT_0597,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,716,01-716-1103,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,3/20/2014,9/20/2014,7/9/2014,,112,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1103,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,3/20/2014,9/20/2014,7/9/2014,,112,7/16/2014,119,8,DAY,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1103,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,3/20/2014,9/20/2014,7/9/2014,,112,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1103,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,3/20/2014,9/20/2014,8/17/2014,,151,8/24/2014,158,8,DAY,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1103,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,3/20/2014,9/20/2014,8/17/2014,,151,8/24/2014,158,8,DAY,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1108,Placebo,0,86,>80,3,WHITE,1,F,Y,2/12/2013,8/10/2013,4/12/2013,,60,NA,NA,NA,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1108,Placebo,0,86,>80,3,WHITE,1,F,Y,2/12/2013,8/10/2013,5/1/2013,,79,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1151,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2/1/2013,5/11/2013,2/19/2013,,19,3/22/2013,50,32,DAY,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,NA,MALIGNANT FIBROUS HISTIOCYTOMA,NA,HLT_0245,NA,HLGT_0507,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",NA,MILD,N,Y,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1151,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2/1/2013,5/11/2013,3/15/2013,,43,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1151,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2/1/2013,5/11/2013,3/15/2013,,43,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1151,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2/1/2013,5/11/2013,2/19/2013,,19,3/22/2013,50,32,DAY,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,NA,MALIGNANT FIBROUS HISTIOCYTOMA,NA,HLT_0245,NA,HLGT_0507,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",NA,MILD,N,Y,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,716,01-716-1157,Xanomeline Low Dose,54,85,>80,3,WHITE,1,M,Y,10/2/2013,4/4/2014,10/17/2013,,16,11/4/2013,34,19,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1157,Xanomeline Low Dose,54,85,>80,3,WHITE,1,M,Y,10/2/2013,4/4/2014,10/25/2013,,24,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1157,Xanomeline Low Dose,54,85,>80,3,WHITE,1,M,Y,10/2/2013,4/4/2014,10/25/2013,,24,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1157,Xanomeline Low Dose,54,85,>80,3,WHITE,1,M,Y,10/2/2013,4/4/2014,10/17/2013,,16,11/4/2013,34,19,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,716,01-716-1160,Placebo,0,83,>80,3,WHITE,1,F,Y,4/5/2013,10/11/2013,5/9/2013,,35,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1160,Placebo,0,83,>80,3,WHITE,1,F,Y,4/5/2013,10/11/2013,5/9/2013,,35,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1167,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,10/8/2012,4/12/2013,11/17/2012,,41,NA,NA,NA,,PRURITUS,ITCH,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1167,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,10/8/2012,4/12/2013,11/17/2012,,41,NA,NA,NA,,SWELLING,SWELLING,NA,SWELLING,NA,HLT_0658,NA,HLGT_0484,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1167,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,10/8/2012,4/12/2013,12/3/2012,,57,NA,NA,NA,,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1167,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,10/8/2012,4/12/2013,3/10/2013,,154,4/10/2013,185,32,DAY,HYPERSENSITIVITY,ALLERGY,NA,HYPERSENSITIVITY,NA,HLT_0473,NA,HLGT_0765,NA,IMMUNE SYSTEM DISORDERS,IMMUNE SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1167,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,10/8/2012,4/12/2013,3/10/2013,,154,4/10/2013,185,32,DAY,HYPERSENSITIVITY,ALLERGY,NA,HYPERSENSITIVITY,NA,HLT_0473,NA,HLGT_0765,NA,IMMUNE SYSTEM DISORDERS,IMMUNE SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,716,01-716-1177,Placebo,0,72,65-80,2,WHITE,1,M,Y,9/2/2014,3/5/2015,8/24/2014,,-9,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1189,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,10/9/2012,2/27/2013,11/24/2012,,47,NA,NA,NA,,HALLUCINATION,HALLUCINATION,NA,HALLUCINATION,NA,HLT_0026,NA,HLGT_0649,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1189,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,10/9/2012,2/27/2013,11/24/2012,,47,NA,NA,NA,,DELUSION,DELUSIONS,NA,DELUSION,NA,HLT_0198,NA,HLGT_0565,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,716,01-716-1189,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,10/9/2012,2/27/2013,1/5/2013,,89,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1189,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,10/9/2012,2/27/2013,2/7/2013,,122,NA,NA,NA,,PROSTATE CANCER,PROSTATE CANCER,NA,PROSTATE CANCER,NA,HLT_0412,NA,HLGT_0190,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",NA,SEVERE,N,Y,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1229,Xanomeline High Dose,81,73,65-80,2,WHITE,1,F,Y,2/20/2013,3/31/2013,2/20/2013,,1,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1229,Xanomeline High Dose,81,73,65-80,2,WHITE,1,F,Y,2/20/2013,3/31/2013,3/6/2013,,15,NA,NA,NA,,BLOOD CHOLESTEROL INCREASED,HIGH CHOLESTEROL,NA,BLOOD CHOLESTEROL INCREASED,NA,HLT_0210,NA,HLGT_0430,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/8/2013,6/28/2013,4/22/2013,,15,7/6/2013,90,76,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/8/2013,6/28/2013,4/22/2013,,15,7/6/2013,90,76,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/8/2013,6/28/2013,6/8/2013,,62,7/6/2013,90,29,DAY,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/8/2013,6/28/2013,4/22/2013,,15,7/6/2013,90,76,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/8/2013,6/28/2013,4/22/2013,,15,7/6/2013,90,76,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,4/8/2013,6/28/2013,6/8/2013,,62,7/6/2013,90,29,DAY,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1308,Placebo,0,76,65-80,2,WHITE,1,F,Y,8/28/2013,10/7/2013,9/20/2013,,24,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1311,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,5/14/2014,9/21/2014,5/28/2014,,15,9/22/2014,132,118,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1311,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,5/14/2014,9/21/2014,7/22/2014,,70,8/2/2014,81,12,DAY,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1311,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,5/14/2014,9/21/2014,8/2/2014,,81,NA,NA,NA,,ULCER,ULCER,NA,ULCER,NA,HLT_0040,NA,HLGT_0245,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1311,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,5/14/2014,9/21/2014,5/28/2014,,15,9/22/2014,132,118,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1364,Xanomeline High Dose,81,84,>80,3,WHITE,1,F,Y,7/4/2013,1/9/2014,8/18/2013,,46,NA,NA,NA,,PRURITUS,ITCH,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1364,Xanomeline High Dose,81,84,>80,3,WHITE,1,F,Y,7/4/2013,1/9/2014,9/2/2013,,61,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1373,Xanomeline High Dose,81,74,65-80,2,WHITE,1,M,Y,12/14/2012,2/27/2013,12/14/2012,,1,NA,NA,NA,,COGNITIVE DISORDER,COGNITIVE IMPAIRMENT,NA,COGNITIVE DISORDER,NA,HLT_0265,NA,HLGT_0506,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1373,Xanomeline High Dose,81,74,65-80,2,WHITE,1,M,Y,12/14/2012,2/27/2013,12/15/2012,,2,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,5/5/2013,11/20/2013,5/5/2013,,1,5/7/2013,3,3,DAY,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,5/5/2013,11/20/2013,5/5/2013,,1,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,5/5/2013,11/20/2013,5/5/2013,,1,5/7/2013,3,3,DAY,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,5/5/2013,11/20/2013,5/7/2013,,3,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,5/5/2013,11/20/2013,7/1/2013,D,58,9/26/2013,145,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,5/5/2013,11/20/2013,7/1/2013,D,58,10/4/2013,153,NA,,VISION BLURRED,BLURRED VISION,NA,VISION BLURRED,NA,HLT_0120,NA,HLGT_0598,NA,EYE DISORDERS,EYE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,5/5/2013,11/20/2013,7/1/2013,D,58,9/26/2013,145,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,5/5/2013,11/20/2013,7/1/2013,D,58,10/4/2013,153,NA,,VISION BLURRED,BLURRED VISION,NA,VISION BLURRED,NA,HLT_0120,NA,HLGT_0598,NA,EYE DISORDERS,EYE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,5/5/2013,11/20/2013,9/26/2013,,145,11/11/2013,191,47,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,5/5/2013,11/20/2013,9/26/2013,,145,11/11/2013,191,47,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,10,Y,,,,,,,,
CDISCPILOT01,716,01-716-1441,Placebo,0,85,>80,3,WHITE,1,M,Y,1/22/2014,7/22/2014,5/11/2014,,110,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1447,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,12/16/2013,6/17/2014,1/1/2014,,17,NA,NA,NA,,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1447,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,12/16/2013,6/17/2014,1/14/2014,,30,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1447,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,12/16/2013,6/17/2014,1/14/2014,,30,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1447,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,12/16/2013,6/17/2014,3/14/2014,,89,NA,NA,NA,,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1447,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,12/16/2013,6/17/2014,4/5/2014,,111,4/9/2014,115,5,DAY,CHEST PAIN,CHEST PAIN,NA,CHEST PAIN,NA,HLT_0717,NA,HLGT_0195,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,5/1/2013,D,-258,NA,NA,NA,,ENURESIS,BED WETTING,NA,ENURESIS,NA,HLT_0107,NA,HLGT_0623,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,1/13/2014,,-1,2/10/2014,28,29,DAY,DIARRHOEA,SOFT STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,N,,,,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,1/15/2014,,2,2/18/2014,36,35,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,Y,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,1/15/2014,,2,2/8/2014,26,25,DAY,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,1/15/2014,,2,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,1/15/2014,,2,NA,NA,NA,,ANXIETY,ANXIETY,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,1/15/2014,,2,NA,NA,NA,,IRRITABILITY,IRRITABILITY,NA,IRRITABILITY,NA,HLT_0627,NA,HLGT_0461,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,1/15/2014,,2,2/8/2014,26,25,DAY,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,1/13/2014,,-1,2/10/2014,28,29,DAY,DIARRHOEA,SOFT STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,10,N,,,,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,1/15/2014,,2,2/18/2014,36,35,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,12,Y,,,,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,4/8/2014,,85,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,15,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,5/21/2014,,128,NA,NA,NA,,BACK PAIN,BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,17,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,6/3/2014,,141,6/10/2014,148,8,DAY,WOUND,WOUND NOS,NA,WOUND,NA,HLT_0542,NA,HLGT_0540,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,18,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,1/14/2014,7/16/2014,6/3/2014,,141,6/10/2014,148,8,DAY,WOUND,WOUND NOS,NA,WOUND,NA,HLT_0542,NA,HLGT_0540,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,19,Y,,,,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,1/27/2014,7/28/2014,1/29/2014,,3,7/16/2014,171,169,DAY,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,1/27/2014,7/28/2014,2/15/2014,,20,2/17/2014,22,3,DAY,HYPERHIDROSIS,SWEATING INCREASED,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,1/27/2014,7/28/2014,2/20/2014,,25,NA,NA,NA,,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,1/27/2014,7/28/2014,2/22/2014,,27,NA,NA,NA,,INSOMNIA,INSOMNIA,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,1/27/2014,7/28/2014,3/4/2014,,37,NA,NA,NA,,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,1/27/2014,7/28/2014,4/18/2014,,82,NA,NA,NA,,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRACTIONS,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,1/27/2014,7/28/2014,1/29/2014,,3,7/16/2014,171,169,DAY,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,717,01-717-1174,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,1/22/2013,7/24/2013,2/3/2013,,13,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1174,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,1/22/2013,7/24/2013,4/17/2013,,86,4/19/2013,88,3,DAY,INSOMNIA,INSOMNIA,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1174,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,1/22/2013,7/24/2013,4/25/2013,,94,4/26/2013,95,2,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1174,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,1/22/2013,7/24/2013,2/3/2013,,13,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1201,Placebo,0,85,>80,3,WHITE,1,F,Y,12/19/2013,2/21/2014,1/15/2014,,28,NA,NA,NA,,ALOPECIA,HAIR LOSS,NA,ALOPECIA,NA,HLT_0077,NA,HLGT_0234,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1344,Placebo,0,64,<65,1,WHITE,1,F,Y,1/11/2014,3/14/2014,2/1/2014,,22,2/6/2014,27,6,DAY,NASAL CONGESTION,NOSE CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,717,01-717-1344,Placebo,0,64,<65,1,WHITE,1,F,Y,1/11/2014,3/14/2014,2/1/2014,,22,2/18/2014,39,18,DAY,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1344,Placebo,0,64,<65,1,WHITE,1,F,Y,1/11/2014,3/14/2014,2/1/2014,,22,2/18/2014,39,18,DAY,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,717,01-717-1344,Placebo,0,64,<65,1,WHITE,1,F,Y,1/11/2014,3/14/2014,2/28/2014,,49,3/1/2014,50,2,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1344,Placebo,0,64,<65,1,WHITE,1,F,Y,1/11/2014,3/14/2014,2/28/2014,,49,3/1/2014,50,2,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,5/1/2013,10/14/2013,4/1/1994,D,-6970,NA,NA,NA,,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,N,,,,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,5/1/2013,10/14/2013,5/29/2013,,29,NA,NA,NA,,OEDEMA PERIPHERAL,ANKLE EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,5/1/2013,10/14/2013,6/11/2013,,42,10/15/2013,168,127,DAY,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,NA,APPLICATION SITE PERSPIRATION,NA,HLT_0283,NA,HLGT_0403,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,5/1/2013,10/14/2013,7/7/2013,,68,7/8/2013,69,2,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,5/1/2013,10/14/2013,7/22/2013,,83,7/22/2013,83,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,5/1/2013,10/14/2013,8/10/2013,,102,8/10/2013,102,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,5/1/2013,10/14/2013,6/11/2013,,42,10/15/2013,168,127,DAY,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,NA,APPLICATION SITE PERSPIRATION,NA,HLT_0283,NA,HLGT_0403,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,9,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,9/1/2013,3/3/2014,9/15/2013,,15,9/16/2013,16,2,DAY,ANXIETY,ANXIETY AGGRAVATED,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,9/1/2013,3/3/2014,9/15/2013,,15,9/16/2013,16,2,DAY,ANXIETY,ANXIETY AGGRAVATED,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,9/1/2013,3/3/2014,10/6/2013,,36,3/3/2014,184,149,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,9/1/2013,3/3/2014,10/7/2013,,37,10/11/2013,41,5,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,9/1/2013,3/3/2014,10/7/2013,,37,10/11/2013,41,5,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,9/1/2013,3/3/2014,1/13/2014,,135,1/14/2014,136,2,DAY,PAIN,STINGING,NA,PAIN,NA,HLT_0314,NA,HLGT_0478,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,9/1/2013,3/3/2014,1/28/2014,,150,NA,NA,NA,,PAIN,STINGING,NA,PAIN,NA,HLT_0314,NA,HLGT_0478,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,9/1/2013,3/3/2014,10/6/2013,,36,3/3/2014,184,149,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,718,01-718-1066,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,7/7/2013,7/16/2013,7/16/2013,,10,7/20/2013,14,5,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1066,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,7/7/2013,7/16/2013,7/18/2013,,12,NA,NA,NA,,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1066,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,7/7/2013,7/16/2013,7/30/2013,,24,NA,NA,NA,,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,718,01-718-1066,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,7/7/2013,7/16/2013,7/30/2013,,24,NA,NA,NA,,INFLAMMATION,INFLAMMATION LOCALIZED,NA,INFLAMMATION,NA,HLT_0582,NA,HLGT_0004,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1079,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,F,Y,9/19/2012,10/31/2012,10/5/2012,,17,NA,NA,NA,,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1079,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,F,Y,9/19/2012,10/31/2012,10/5/2012,,17,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1079,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,F,Y,9/19/2012,10/31/2012,10/5/2012,,17,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1101,Xanomeline High Dose,81,82,>80,3,BLACK OR AFRICAN AMERICAN,2,M,Y,2/17/2013,7/31/2013,3/6/2013,,18,3/6/2013,18,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1101,Xanomeline High Dose,81,82,>80,3,BLACK OR AFRICAN AMERICAN,2,M,Y,2/17/2013,7/31/2013,4/13/2013,,56,5/12/2013,85,30,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1101,Xanomeline High Dose,81,82,>80,3,BLACK OR AFRICAN AMERICAN,2,M,Y,2/17/2013,7/31/2013,4/14/2013,,57,7/6/2013,140,84,DAY,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1101,Xanomeline High Dose,81,82,>80,3,BLACK OR AFRICAN AMERICAN,2,M,Y,2/17/2013,7/31/2013,4/13/2013,,56,5/12/2013,85,30,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,718,01-718-1101,Xanomeline High Dose,81,82,>80,3,BLACK OR AFRICAN AMERICAN,2,M,Y,2/17/2013,7/31/2013,4/14/2013,,57,7/6/2013,140,84,DAY,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,718,01-718-1139,Placebo,0,77,65-80,2,WHITE,1,M,Y,5/19/2013,11/17/2013,6/3/2013,,16,7/16/2013,59,44,DAY,SOMNOLENCE,SLEEPINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1139,Placebo,0,77,65-80,2,WHITE,1,M,Y,5/19/2013,11/17/2013,6/3/2013,,16,7/16/2013,59,44,DAY,SOMNOLENCE,SLEEPINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,718,01-718-1139,Placebo,0,77,65-80,2,WHITE,1,M,Y,5/19/2013,11/17/2013,11/16/2013,,182,11/16/2013,182,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,1/19/2013,7/29/2013,2/16/2013,,29,3/17/2013,58,30,DAY,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,1/19/2013,7/29/2013,3/6/2013,,47,3/26/2013,67,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,1/19/2013,7/29/2013,3/15/2013,,56,3/15/2013,56,1,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,1/19/2013,7/29/2013,2/16/2013,,29,3/17/2013,58,30,DAY,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,1/19/2013,7/29/2013,3/6/2013,,47,3/26/2013,67,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,1/19/2013,7/29/2013,5/10/2013,,112,7/7/2013,170,59,DAY,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,1/19/2013,7/29/2013,6/9/2013,,142,NA,NA,NA,,FOOD CRAVING,CARBOHYDRATE CRAVING,NA,FOOD CRAVING,NA,HLT_0754,NA,HLGT_0376,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,1/19/2013,7/29/2013,6/16/2013,,149,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,1/19/2013,7/29/2013,5/10/2013,,112,7/7/2013,170,59,DAY,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,1/19/2013,7/29/2013,7/31/2013,,194,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,9/16/2013,10/12/2013,10/7/2013,,22,10/7/2013,22,1,DAY,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,9/16/2013,10/12/2013,10/11/2013,,26,10/12/2013,27,2,DAY,HYPERHIDROSIS,DIAPHORESIS,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,9/16/2013,10/12/2013,10/11/2013,,26,10/12/2013,27,2,DAY,BODY TEMPERATURE INCREASED,TEMPERATURE ELEVATION,NA,BODY TEMPERATURE INCREASED,NA,HLT_0734,NA,HLGT_0351,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,9/16/2013,10/12/2013,10/11/2013,,26,10/12/2013,27,2,DAY,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,9/16/2013,10/12/2013,10/12/2013,,27,10/13/2013,28,2,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,Y,N,N,N,N,Y,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,Y,Y,Y,Y,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,9/16/2013,10/12/2013,10/16/2013,,31,NA,NA,NA,,AGITATION,INCREASED AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,9/21/2013,1/31/2014,10/9/2013,,19,11/15/2013,56,38,DAY,BALANCE DISORDER,UNSTEADINESS,NA,BALANCE DISORDER,NA,HLT_0541,NA,HLGT_0101,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,9/21/2013,1/31/2014,10/9/2013,,19,10/9/2013,19,1,DAY,FALL,FALL,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,9/21/2013,1/31/2014,10/15/2013,,25,11/2/2013,43,19,DAY,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,9/21/2013,1/31/2014,10/9/2013,,19,11/15/2013,56,38,DAY,BALANCE DISORDER,UNSTEADINESS,NA,BALANCE DISORDER,NA,HLT_0541,NA,HLGT_0101,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,9/21/2013,1/31/2014,10/15/2013,,25,11/2/2013,43,19,DAY,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,9/21/2013,1/31/2014,10/9/2013,,19,11/15/2013,56,38,DAY,BALANCE DISORDER,UNSTEADINESS,NA,BALANCE DISORDER,NA,HLT_0541,NA,HLGT_0101,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,9/21/2013,1/31/2014,10/15/2013,,25,11/2/2013,43,19,DAY,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,9/21/2013,1/31/2014,11/15/2013,,56,11/15/2013,56,1,DAY,COORDINATION ABNORMAL,INCOORDINATION,NA,COORDINATION ABNORMAL,NA,HLT_0315,NA,HLGT_0015,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,9/21/2013,1/31/2014,12/29/2013,,100,2/19/2014,152,53,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,9/21/2013,1/31/2014,12/29/2013,,100,2/19/2014,152,53,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,9/21/2013,1/31/2014,12/29/2013,,100,2/19/2014,152,53,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,7/10/2013,1/9/2014,8/13/2013,,35,NA,NA,NA,,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLORATION,NA,APPLICATION SITE DISCOLOURATION,NA,HLT_0121,NA,HLGT_0273,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,7/10/2013,1/9/2014,8/13/2013,,35,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,7/10/2013,1/9/2014,9/3/2013,,56,9/19/2013,72,17,DAY,SOMNOLENCE,SOMNOLENCE,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,7/10/2013,1/9/2014,9/3/2013,,56,9/19/2013,72,17,DAY,SOMNOLENCE,SOMNOLENCE,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,7/10/2013,1/9/2014,10/31/2013,,114,NA,NA,NA,,FOOD CRAVING,CARBOHYDRATE CRAVING,NA,FOOD CRAVING,NA,HLT_0754,NA,HLGT_0376,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,7/10/2013,1/9/2014,10/31/2013,,114,NA,NA,NA,,DYSPHAGIA,SWALLOWING DIFFICULT,NA,DYSPHAGIA,NA,HLT_0563,NA,HLGT_0405,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1328,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,2/1/2013,4/18/2013,3/23/2013,,51,3/25/2013,53,3,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1328,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,2/1/2013,4/18/2013,3/23/2013,,51,3/25/2013,53,3,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1328,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,2/1/2013,4/18/2013,4/2/2013,,61,4/21/2013,80,20,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1328,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,2/1/2013,4/18/2013,4/2/2013,,61,4/21/2013,80,20,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,3/8/2013,,9,3/22/2013,23,15,DAY,SKIN ULCER,SKIN EROSION,NA,SKIN ULCER,NA,HLT_0005,NA,HLGT_0017,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,3/8/2013,,9,3/22/2013,23,15,DAY,SKIN ULCER,SKIN EROSION,NA,SKIN ULCER,NA,HLT_0005,NA,HLGT_0017,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,NA,,NA,NA,NA,NA,,DERMATITIS ATOPIC,ATOPIC DERMATITIS,NA,DERMATITIS ATOPIC,NA,HLT_0480,NA,HLGT_0257,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,N,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,4/17/2013,,49,NA,NA,NA,,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,4/27/2013,,59,4/27/2013,59,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,5/12/2013,,74,5/12/2013,74,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,5/16/2013,,78,5/16/2013,78,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,5/20/2013,,82,5/20/2013,82,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,5/25/2013,,87,NA,NA,NA,,SOMNOLENCE,SLEEPINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,6/23/2013,,116,8/13/2013,167,52,DAY,APPLICATION SITE REACTION,APPLICATION SITE REACTION,NA,APPLICATION SITE REACTION,NA,HLT_0339,NA,HLGT_0668,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,6/23/2013,,116,8/13/2013,167,52,DAY,APPLICATION SITE REACTION,APPLICATION SITE REACTION,NA,APPLICATION SITE REACTION,NA,HLT_0339,NA,HLGT_0668,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,8/15/2013,,169,8/29/2013,183,15,DAY,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,12,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2/28/2013,8/29/2013,8/15/2013,,169,8/29/2013,183,15,DAY,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,13,Y,,,,,,,,
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,4/26/2013,8/1/2013,5/9/2013,,14,5/11/2013,16,3,DAY,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,4/26/2013,8/1/2013,5/9/2013,,14,5/11/2013,16,3,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,4/26/2013,8/1/2013,5/24/2013,,29,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,4/26/2013,8/1/2013,6/2/2013,,38,6/5/2013,41,4,DAY,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALIZATION,NA,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NA,HLT_0603,NA,HLGT_0719,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,Y,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,Y,Y,Y,Y,Y,,
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,4/26/2013,8/1/2013,6/2/2013,,38,6/3/2013,39,2,DAY,"HALLUCINATION, VISUAL",VISUAL HALLUCINATIONS,NA,"HALLUCINATION, VISUAL",NA,HLT_0369,NA,HLGT_0663,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,4/26/2013,8/1/2013,5/24/2013,,29,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,12/18/2012,,2,12/18/2012,2,1,DAY,BACK PAIN,BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,12/26/2012,,10,12/26/2012,10,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,1/1/2013,,16,1/19/2013,34,19,DAY,AMNESIA,SHORT-TERM MEMORY LOSS,NA,AMNESIA,NA,HLT_0501,NA,HLGT_0641,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,1/3/2013,,18,1/9/2013,24,7,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,1/5/2013,,20,1/5/2013,20,1,DAY,LETHARGY,LETHARGY,NA,LETHARGY,NA,HLT_0027,NA,HLGT_0448,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,1/16/2013,,31,1/16/2013,31,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,1/1/2013,,16,1/19/2013,34,19,DAY,AMNESIA,SHORT-TERM MEMORY LOSS,NA,AMNESIA,NA,HLT_0501,NA,HLGT_0641,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,1/21/2013,,36,1/24/2013,39,4,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,1/27/2013,,42,1/28/2013,43,2,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,1/27/2013,,42,1/27/2013,42,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,10,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,1/27/2013,,42,1/28/2013,43,2,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,1/29/2013,,44,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,12,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,2/4/2013,,50,2/25/2013,71,22,DAY,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,13,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,2/4/2013,,50,2/25/2013,71,22,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,14,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,2/4/2013,,50,2/25/2013,71,22,DAY,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,15,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,12/17/2012,2/11/2013,2/4/2013,,50,2/25/2013,71,22,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,16,Y,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
